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“Man, lucky me,  
I was diagnosed with a heart disease at nineteen 
Could barely stand on my feet 
Doctor said they had to cut it open, put a pacemaker on it to put it back on beat 
'Til my mama took me to holistic doctors and they prescribed me magnesium for two weeks 
Went back to the regular doctors and they said, 
‘Huh, damn, looks like we don't need to proceed,’ 
That's how I know that Western medicine’s weak. 
Man, lucky me.” 
Big Sean - “Lucky Me” 
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The U.S. Healthcare system is struggling to manage the burden of chronic disease, racial 
and socio-economic disparities, and the debilitating impact of the current global pandemic 
caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). More patients need 
alternatives to allopathic or “Western” medicine focused on fighting disease with mechanism, 
pharmaceuticals, and invasive measures. They are seeking Integrative Medicine which focuses 
on health and healing, emphasizing the centrality of the patient-physician relationship. In 
addition to providing the best conventional care, IM focuses on preventive maintenance, 
wellness, improved behaviors, and a holistic care plan.  
This qualitative research assessed whether predictive and prescriptive analytics (artificial 
intelligence tools that predict patient outcomes and recommend treatments, interventions, and 
medications) supports the decision-making processes of IM practitioners who treat patients 
suffering from chronic pain. PPA was used in a few U.S. hospitals but was not widely available 
for IM practitioners at the time of this research. Phenomenological interviews showed doctors 
benefit from technology that aggregates data, providing a clear patient snapshot. PPA exposed 
historical information that doctors often miss. However, current systems lacked the design to 
manage individualized, holistic care focused on the mind, body, and spirit.  
Using the Future-Focused Task-Technology Fit theory, the research suggested PPA could 
actually do more harm than good in its current state. Future technology must be patient-focused 
and designed with a better understanding of the IM task and group characteristics (e.g., the 
unique way providers practice medicine) to reduce algorithm aversion and increase adoption. In 
the ideal future state, PPA will surface healthcare Big Data from multiple sources, support 
communication and collaboration across the patient’s support system and community of care, 
and track the various objective and subjective factors contributing to the path to wellness. 
 
INDEX WORDS: Artificial Intelligence, Future-Focused Task-Technology Fit Theory, 





I.1 U.S. Healthcare System in Crisis 
In 2021, the U.S. Healthcare system continued to struggle with the impact of chronic 
disease, the unfortunate reality of racial and socio-economic disparities (including limited access 
to care and poorer outcomes for underrepresented populations), and the uncontrolled cost of care. 
The United States ranked 20th in the “Overall RCII” ranking for countries across Governance, 
Economics, Operations, and Society variables. However, when compared to all countries for 
Health the U.S. dropped to 32nd with the worst overall scores for substance abuse (Robinson 
Country Intelligence Index, Georgia State University, 2020). 
The debilitating effects of the 2020-2021 global pandemic caused by severe acute 
respiratory syndrome coronavirus-2 (SARS-CoV-2) exposed gaps in the U.S. Public Health 
infrastructure and epidemiological/surveillance mechanisms (e.g., tracking and tracing Covid-
positive people). The U.S. had a delayed and lackluster response to the epidemic which led to 33.7 
million confirmed cases and 605,000 deaths by July 1, 2021 (“U.S. Map,” 2021).  American 
families and businesses felt the resultant strain. State and local governments imposed different 
flavors of stay-at-home mandates; requirements about social distancing, wearing masks and taking 
temperatures; and either asked certain businesses (e.g., bars, restaurants, concert halls, etc.) to 
close down for periods of time or meet safety requirements to stay open and avoid fines. Essential 
workers like physicians, nurses, and medical laboratory professionals took risks to provide services 
with the threat of potential infection; potentially with limited access to adequate personal 
protective equipment. 
Non-essential workers who were fortunate enough not to lose their jobs, elementary 
schoolers, and college students accepted a new reality of virtual and remote work and learning; 
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operating away from their usual social settings, isolated in their home environments, using web-
based collaboration tools to communicate. The pain of isolation, loss of loved ones, and lack of 
visibility into an uncertain future added a strain on the mental healthcare system which was 
already struggling before Covid-19. The compounded impact of the pandemic on the collective 
mental health of Americans would take longer to manifest (e.g., time between trauma and 
presentation of a patient before a medical professional) and become measurable outcomes.  
It was within this dire reality that this study was birthed-the will to uncover a path to better 
health for all. The current renaissance, Americans seeking alternatives to allopathic or Western 
medicine, started in the 1990’s as more patients turned to integrative medicine (IM) and 
naturopathic practitioners (naturopaths) to be healed (Lee & Kemper, 2000). IM differed from 
allopathic medicine by applying more focus on the patient and provider relationship, using a 
combination of allopathic medicine methods with complementary and alternative medicine 
(CAM). IM used a holistic approach or “multi-modal interventions” to treat patients, including a 
theoretical foundation in preventative medicine to maintain wellness (Oberg et al., 2015).  
Predictive and prescriptive analytics tools (PPA) were piloted in large hospital systems in 
the last few years to predict patient health outcomes and prescribe treatments (Oesterreich, Fitte, 
Behne, & Teuteberg, 2020). As of 2021, PPA tools were not developed for or marketed to primary 
care providers. Based on preliminary conversations with IM practitioners, they primarily used 
electronic medical records (EMR) and electronic health records (EHR). EMR was the standard 
technology to collect a digital patient chart and manage longitudinal data like medical history, 
diagnoses, and lab results. EHR aggregated health information shared across multiple practices, 
health systems, and state-based healthcare exchanges. Practitioners used their own medical 
training (and feedback from peers), professional experiences, and intuition to predict patient 
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outcomes and make medical decisions. They had limited understanding of how PPA could be 
applied to primary care; but practitioners were intrigued to understand how these tools might one 
day be applied to their profession. One practitioner held deep skepticism and did not believe 
emerging technology could mimic the complexity of her medical decision-making (MDM) process 
focused on providing whole body care to her patients.  
This research took a qualitative approach to explore the potential for future convergence 
of IM and emerging technology to heal patients. The main research question is: 
How can predictive and prescriptive analytics tools (PPA) support/innovate 
integrative medicine (IM) decision-making processes and improve outcomes for patient 
populations suffering from chronic pain? 
This research sought to examine the unique dance that occurred between doctors and 
patients along the healing process (see Research Design Summary in Appendix A). A deeper 
understanding of the nuance or “essence” in the way IM practitioners made medical decisions (Van 
Manen, 1990) could help answer the following secondary research questions: 
1) How do IM providers describe the tasks they consistently perform (e.g., the steps in evidence-
based MDM)? 
2) How do IM providers perceive the PPA technology currently being used in U.S. hospitals to 
predict patient outcomes and provide recommendations to providers?  
3) How can an understanding of current IM practice be used to identify the potential usefulness 
of PPA and high-level future requirements? 
To increase the likelihood of focused, impactful conversations with medical professionals 
the scope was reduced to one medical indication. This research focused on medical decisions 
made during the treatment of chronic pain, one of the top five most prevalent U.S. health issues 
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(Oberg et al., 2015). This population choice ensured there would be a large enough sample of 
potential research participants. Also, the complexity of treating patients presenting with chronic 
pain was identified as a factor that could lead to interesting insights. 
A technology vendor (whose pseudonym is PPATech in this paper) supported this research, 
hoping to gain feedback from healthcare providers that operated outside of hospital systems. PPA 
developers lacked understanding of how primary care providers who practiced IM perceived their 
suite of software-as-a-service (SaaS) products. PPATech provided three visualizations to share 
with research participants, screenshots of real-world chronic pain scenarios. IM practitioners 
provided feedback on the user interface. Their overall perceptions of PPA (values, beliefs, and 
attitudes) and critique were used to identify how the technology may or may not fit into their 
workflow.   
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II LITERATURE REVIEW 
The literature review included a stepwise search for peer-reviewed journals in three 
separate databases: Web of Science, EBSCO, and PubMed. The initial searches included the 
following topics to find articles on emerging technology: 
▪ (“PPA” or “predictive analytics” OR “prescriptive analytics” OR “machine learning” OR 
“artificial intelligence” OR “big data” OR “AI”) 
There was a large swath of results: EBSCO (15,215), Web of Science (393,084) and PubMed 
(92,122). Additional search topics were added systematically to identify articles that also focused 
on the medical field: 
▪ (“medicine” OR “medical” OR “healthcare” OR “provider” OR “doctor”) 
▪ (“decision making” OR “treatment” OR “intervention” OR “recommendations” OR 
“recommend” OR “care” OR “patient”) 
▪ (“integrative”) 
Selected abstracts were analyzed to identify the research approach, empirical basis, analysis 
method, and overall validity of the study results. A subset of articles provided U.S trends in 
holistic patient care, definitions of IM, definitions of PPA and application to healthcare. 
Six articles provided confirmation that research on the convergence of IM and PPA had 
value. All six were recognized by Web of Science with Journal Impact Scores between 0.959 to 
4.225. The six papers had a wide range of visibility, being cited between 2 and 250+ times. 
These publications included a mix of qualitative and quantitative research, including literature 
reviews, theoretical papers, AI/ML modeling and a numerical analysis of doctor intake forms. 
Additional details about study validity and key findings were included in Appendices B and C). 
The literature review confirmed IM helps complex patients who need an alternative to allopathic 
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medicine (Young & Kemper, 2013). These patients tend to seek IM after receiving less than 
satisfactory results or no relief from chronic pain after visiting their primary care provider. 
The next set of findings focused on limitations in the technology. The need for further 
research was identified for external validation, implementation logistics, and data exchange and 
privacy (Angehrn et al., 2020). For AI to have full benefit, it must pull together disparate data 
sources in a manner that protects patient privacy. “Socio-economic, gender, and race 
characteristics” were important factors for refining algorithms. However, surfacing this type of 
data via the AI user interface could create bias amongst doctors and/or allow for misuse of PPA 
tools (Prosperi, Min, Bian, & Modave, 2018). 
Unique applications of AI to healthcare were well described in the literature. Within a 
well understood patient population, the algorithms were very accurate at predicting further 
disease/illness (Geng et al., 2020). However, use of AI to make predictions across multiple 
physiological systems not well understood (Ching et al., 2018). Increased complexity of disease 
states made it very difficult to predict progression with accuracy or recommend a comprehensive 
list of potential treatment modalities and medicines. AI was often used to predict health 
outcomes (system-by system or for one disease state). Thus, adoption of AI was described as a 
gradual process and additional research would be needed to avoid incorrect application (Chin-
Yee & Upshur, 2019).  
IM had clear benefits (especially to patients suffering from complex conditions) and the 
shift to personalized healthcare was predicted to continue. So, there could be a market for 
technology supporting IM in the future. However, peer-reviewed articles about application of AI 
at the point of care, the real-world experience of introducing emerging technology, measuring 
effectiveness, and encouraging adoption were lacking. 
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The next round of search focused on the study case: treating chronic pain. Seventeen 
articles were identified to understand medical definitions of this condition, compounding factors, 
and U.S. trends. The identified papers highlighted treatment and intervention options, including 
many CAM modalities. Articles also described how predictive modeling of patient outcomes is 
being applied to this disease state. 
To understand how to identify the potential fit between IM and PPA, a separate literature 
review was performed. The initial searches for the key phrase “Task-Technology Fit” provided 
the following results for academic journals: EBSCO (5,697), Web of Science (511) and PubMed 
(31). Filtering for “Healthcare” reduced the list to 1,541; 13; and 15, respectively. A final search 
adding the terms “artificial intelligence” only provided one relevant result. Thus, while research 
on TTF in Healthcare was rather saturated, the focus of this study (e.g., identifying fit of 
emerging technology) was quite novel. 
The following sections describe the three literature review streams: IM decision making, 
Predicting and Prescriptive Analytics, and treating patients with chronic diseases. 
II.1 Integrative Medicine (IM) Decision-Making 
IM applied more focus on the patient and provider relationship, using a combination of 
allopathic medicine methods with complementary and alternative medicine (CAM). IM used a 
holistic approach or “multi-modal interventions” to treat patients, including a theoretical 
foundation in preventative medicine to maintain wellness (Oberg et al., 2015).  Mechanism and 
vitalism sat on two separate sides of the healthcare spectrum. Mechanism focused on the 
mechanics of diagnosing the root cause of disease and decreasing, extracting, or eliminating the 
issue. In stark contrast, vitalism sought to promote overall mental, physical and spiritual 
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wellness, use preventive care to reduce likelihood of illness, and take advantage of the body’s 
ability to maintain homeostasis within physiological systems. 
Along this spectrum, the typical primary care doctor trained in the U.S. system practiced 
some form of mechanism with varying desire, understanding, and ability to choose less invasive 
measures to treat patients. Primary care doctors typically prescribed biomedical treatment (e.g., 
pharmaceutical products) to reduce symptoms and/or eliminate the disease. This familiar pattern 
of allopathic medicine, called “Western Medicine” because of its modern rebirth in Europe and 
the U.S., was often described as “traditional medicine” in the literature.  
Allopathic medicine relied on an inductive process or series of questions to identify the 
likely cause of disease and remove it: identify and treat (Zejf, Snider, & Myers, 2019). Primary 
doctors, family care doctors, pediatricians or generalists treated a subset of general causes of 
disease. If these treatments were seen as unsuitable or did not have the intended effect, the 
patient would be referred to a specialist who also practiced some form of mechanism (e.g., a 
cardiologist to implant a stent, an oncologist to initiate radiology or chemotherapy treatments, or 
a specialty surgeon to perform a hip replacement). A patient with serious problems had multiple 
doctors treating one or more issues. However, the overall nature of the care was not holistic (e.g., 
not focused on whole body, mental health and spirituality). 
A second body of medical care, complementary and alternative medicine (CAM), was 
described based on its relationship to allopathic medicine (Pang et al., 2015) (Barrett et al., 2003) 
(Naliboff, 2002): 
▪ Complementary: used along with allopathic medicine 
▪ Alternative: used instead of allopathic medicine 
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The seemingly endless number of different modalities or treatment options in CAM 
varied across articles; but often included mindfulness, yoga, chiropractic, acupuncture, and 
massage therapy (Naliboff, 2002). Finally, in contrast to biomedicine as the first choice, 
providers using CAM sought to prescribe treatments with a safer side effect profile like dietary 
supplements, herbal remedies, and homeopathic options where appropriate.   
In the literature, CAM and Naturopathic Medicine (NM) were sometimes described 
interchangeably when referencing a specific modality. However, NM was more often described 
as a separate health practice whose practitioners focused on “the restoration of health” and 
viewed disease more as a set of physiological processes that had broken within a person rather 
than an entity to remove (Zejf et al., 2019). Practitioners upheld strong beliefs that “vitalism 
leads to a perspective of health and health care that is uniquely beneficial to helping patients 
solve their health problems” (Amy Neil MS, 2019; Coulter, Snider, & Neil, 2019). 
The description of NM varied greatly by country; but was generally defined as “a system 
of primary health care: an art, science, philosophy, and practice of diagnosis, treatment, and 
prevention of illness (Wardle, Adams, Lui, & Steel, 2013).” Naturopathic modalities included 
therapies “to detoxify…eating clean, habit and lifestyle modification…and hydrotherapy (steam, 
hot tub use, colonic irrigation)” (Lee & Kemper, 2000). 
In 2020, there were approximately 6,000 licensed U.S. naturopaths who achieved 
advanced degrees (Naturopathic, 2020); including “doctors, dentists, nurses, midwives, 
pharmacists and physical therapists who provide [traditional medicine]/CAM services to their 
patients” and practitioners who use the vast sum total, methods and healing systems from 
indigenous cultures (WHO, 2019) (Naliboff, 2002). Thus, the term “traditional” more accurately 
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described the CAM modality of African herbalists or Chinese acupuncturists developed 
thousands of years before the allopathic methods used in the U.S. 
The literature addressed the lack of understanding and distrust found in U.S. culture 
towards CAM modalities. Skepticism existed due to at least the following five factors: 
▪ Research on CAM practice and outcomes is in its infancy 
▪ Inability to conduct double-blind clinical trials for many modalities 
▪ Lack of U.S. state-accepted licensure for the practice of many modalities 
▪ General lack of public knowledge due to the misrepresentation of certain practices 
▪ Negative results and/or malpractice from charlatans claiming to practice CAM 
There were misconceptions about how doctors applied CAM/NM. And most U.S. citizens 
were unaware naturopaths received medical training (4 years) or that many MDs added CAM 
disciplines to their practice (Oberg et al., 2015) (Lee & Kemper, 2000). Negative references to 
naturopaths as fake doctors may also be attributed to the “common co-option of the naturopathic 
identity by other less-trained practitioners” (Wardle et al., 2013). Additional descriptions of the 
types of medical practice and the wide variety of modalities was included in Appendix D. 
Based on survey data from the 2000s, U.S. patients tended to seek CAM therapies after 
going to their primary care doctor first with a preference for complementary approaches over 
alternative medicine (Naliboff, 2002). Patients with chronic or life-threatening conditions were 
more likely to move to nonconventional modalities (Sniderman, D’Agostino Sr, & Pencina, 
2015). Patients who adopted CAM found satisfaction in its holistic and empowering nature 
(Barrett et al., 2003), including longer visits with practitioners who took a more intuitive 
approach to understanding the whole needs of the patient before suggesting care and/or offering 
a referral to another healthcare provider.  
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IM developed as a solution to the growing issues in U.S. Healthcare, focused on both 
allopathic medicine and healing, with the patient-provider relationship at its crux (Snyderman & 
Weil, 2002). IM addressed patient’s holistic needs, including the importance of maintaining a 
healthy lifestyle. And the practice required care providers “to serve as guides, role models, and 
mentors, as well as dispensers of therapeutic aids” (Snyderman & Weil, 2002).  
This research was designed to understand the essence of how IM providers make medical 
decisions. Based on Horrigan et al., IM addressed “the full range of physical, emotional, mental, 
social, spiritual, and environmental influences that affected a person’s health” (Horrigan, Lewis, 
Abrams, & Pechura, 2012). The following basic assumptions were identified by Horrigan et al.:  
▪ The patient and practitioner are partners in the healing process.  
▪ All factors that influence health, wellness, and disease are taken into consideration.  
▪ The care addresses the whole person, including body, mind, and spirit in the context of 
community.  
▪ Practitioners use all appropriate healing sciences to facilitate the body’s innate healing 
response. 
▪ Effective interventions that are natural and less invasive are used whenever possible.  
▪ Because good medicine is based in good science, IM is inquiry-driven and open to new 
models of care.  
▪ Alongside the concept of treatment, the broader concepts of health promotion and the 
prevention of illness are paramount.  
▪ Care is individualized to best address the person’s unique conditions, needs, and 
circumstances. 
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▪ Practitioners of IM exemplify its principles and commit themselves to self-exploration and 
self-development.  
When considering technology used to predict patient outcomes, IM practitioners would expect 
the system to address the list above (Horrigan et al., 2012). 
IM allowed the primary care provider to “involve the patient as an active partner in his or 
her care” (Sniderman et al., 2015). They used preventative care measures to maintain wellness; 
homeopathic, NM and biomedicine to treat disease (seeking the least harmful options first); and 
more invasive or mechanistic measures to treat a very sick patient. Madsen et al. illustrated the 
increasing level of overlap between techniques used in IM and conventional medicine: CAM 
modalities like acupuncture and chiropractic were being taught in U.S. medical schools and 
cognitive-behavioral therapy was offered and reimbursed by insurance payers as an IM modality 
(Madsen, Vaughan, & Koehlmoos, 2017).  
Based on the World Health Organization 2019 report, the U.S. sought to expand coverage 
of “essential health services” in response to rising healthcare costs (WHO, 2019).” As consumer 
expectations for [better, more personalized] care rose,” so did healthcare costs (WHO, 2019). 
However, only 22 U.S. states recognized the naturopathic license ("Regulated States and 
Regulatory Authorities," 2020) and reimbursement for CAM/NM services varied based on the 
patient’s insurance provider, forcing many to pay for care out of pocket. U.S. insurance payer 
reimbursement continued to shift to an outcomes-based model reliant on proving patient 
outcomes through analytics (Ohnuma, Shinjo, Brookhart, & Fushimi, 2018), making it critical to 
understand how an ecosystem including IM care would be supported.  
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II.2 Predictive and Prescriptive Analytics (PPA) 
Big Data analytics powered by AI changed the healthcare industry, transforming how 
healthcare providers made accurate decisions off of the data housed in EHR (Lodhi et al., 2015) 
(Lin, Chen, Brown, Li, & Yang, 2017) and identified the best personalized care options for 
unique patients (Rowh, 2019) (Paul Tiffin, 2018). The resultant impact included efficiency in 
treating patients before their condition worsens with reduced impact on the healthcare system 
(e.g., lower costs) (Nambiar, Bhardwaj, Sethi, & Vargheese, 2013) (Dasgupta, 2019).   
Using machine computing or machine learning (ML), algorithms combed through 
longitudinal data (e.g., historical data found in a patient charts, images, “laboratory, pharmacy, 
insurance, and other administrative data”) that were too large to manage with “traditional or 
common data management tools” (Raghupathi & Raghupathi, 2014). As decision complexity 
increased, neural network algorithms, which mimic the nerve signaling of the human brain, were 
often used to “model any relationship between an observed variable…and an outcome” (Miner et 
al., 2014). Predictive analytics used real-world settings and data to validate the algorithm and 
improve the model (Cohen, Amarasingham, Shah, Xie, & Lo, 2014). Then, patients’ actual 
outcomes were fed back into the statistical models to make the system more accurate over time 
(Cognitive Computing, 2020).  
Oesterreich et al. conducted a meta-analysis of 492 peer-reviewed journals with key-word 
hits in the realm of PPA and healthcare. They also interviewed nine experts to confirm the 
definition of PPA, identify use cases/application to healthcare, and identify the ideal future state 
(Oesterreich et al., 2020). Predictive analytics were focused on “health effects: and prescriptive 
analytics recommended next steps to avoid those affects and maintain…health” (Oesterreich et 
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al., 2020). This definition was curiously aligned to the preventive medicine and sustainable 
wellness goals of IM.  
Oesterreich et al. referenced the continuum of technology that provides insights to 
healthcare providers. The Davenport and Harris article described a 2-by-2 relationship between 
impact on an industry and the sophistication of the analytics tool (Davenport & Harris, 2017). 
Figure 1 applied the spectrum to healthcare, identifying high-level questions analytics could 
answer for IM providers. 
 
Figure 1: Diversity of Big Data and Analytics Technology Applied to Healthcare 
Adapted from Figure 1 from (Oesterreich et al., 2020), the scale above described Big 
Data and Analytics in a model where Healthcare Impact is a function of technology 
sophistication. While descriptive statistics tell us what happened in the past, highly sophisticated 
autonomous analytics will “employ artificial intelligence to create self-learning and self-
optimizing models” (Davenport & Harris, 2017) (Oesterreich et al., 2020). These autonomous 
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systems would mimic the minds of medical professionals, seeking to apply learnings/medical 
knowledge to new patient populations or disease states. 
Over time the healthcare analytics market will include more vendors and niche software 
companies that develop platforms to manage diverse data inputs, complex conditions and 
diseases, mental health applications (Hahn, Nierenberg, & Whitfield-Gabrieli, 2017). The 
reading mentioned the development of applications outside of the hospital settings to “transform 
how clinical decisions are made” (Dupre et al., 2017; Peterson, 2019).  
 Specific to the patient’s condition, PPA can predict medical complications (Stevens et al. 
2001) (Peterson, 2019), likelihood of hospital readmission (Bardhan et al. 2014), expected 
response to treatment (Meyer et al. 2014), and patient mortality (Tabak et al. 2014). PPA tools 
often provide “risk scoring” which “computes the probability that certain, predetermined events 
in a patient's trajectory take place” (Mueller-Peltzer et al., 2020). As the algorithms are refined, 
this software predicted a patient’s expected health outcomes with increasing levels of statistical 
confidence (Kansagara et al., 2011) (Rowh, 2019), automated tasks in the MDM process 
(Dasgupta, 2019), and lowered overall healthcare costs (Paul Tiffin, 2018).  
In one study, medical practitioners identified two additional types of data that would 
provide valuable context to the risk score: “patient-reported symptoms (e.g., pain, limitations in 
function) and modifiable clinical risk factors important to predicting outcomes (e.g., BMI, 
smoking, emotional health)” (Franklin, Zheng, Bond, & Lavallee, 2020). These “patient-reported 
health status and symptoms” may not be consistently captured in EHR today (Franklin et al., 
2020). Execution of care was another major variable. For example, a homeless patient may not 
have access to technology. Or they may be hard to locate, making follow-up steps nearly 
impossible to implement or monitor.   
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Since it is currently unrealistic to quantify and capture all “future predictors and 
processes that contribute to future events… estimates of risk,” PPA is only as powerful 
(Sniderman et al., 2015) as the quality and completeness of the data used to validate the 
algorithm. Also, the protocols associated with patients’ care are very different based on disease 
state (Petersen et al., 2018). For example, the treatment protocols for a Type 2 diabetes patient 
(Thomas, 2018) and for patients originally hospitalized with cardiovascular disease (Dupre et al., 
2017) would be specific to each population.  The “interpretability” needed to understand the 
nuanced differences in predications based on “disease trajectories” is very complex (Mueller-
Peltzer et al., 2020), so algorithms which “follow a simple set of rules and logic” may make it 
easier to interpret the results or outputs (Miner et al., 2014). As PPA evolves along the 
sophistication spectrum, the analytics should predict patient outcomes “under novel 
circumstances” and clearly present the options for care (Chin‐Yee & Upshur, 2018). 
The literature provided several examples of limitations to predictive models. The most 
serious limitation was bias. Any bias in how the patient population was selected to develop the 
algorithm would expose the technology to inaccurate predictions (Chin‐Yee & Upshur, 2018). 
Also, the exclusion of important variables as inputs (e.g., using a solely Allopathic view to select 
clinical health factors), would bias the prescriptive outputs toward mechanism and more invasive 
treatment methods. There reading described a future “opportunity to transform the consciousness 
embedded in artificial intelligence, since it is in fact, in part, a part of our own collective 
creation” (Noble, 2018).  
Existing risk models typically focused on one specific event or disease state and did not 
predict multiple outcomes (Lin et al., 2017). Predictive models accurately explained “group 
risk,” but struggled to estimate the personalized situation or needs of one patient (Sniderman et 
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al., 2015) and imperfectly explain clinical outcomes. Due to limitations in a nascent, emerging 
technology, the models for predicting patient readmission rates or risk prediction models 
(Kansagara et al., 2011) only accurately predicted for a subset of the patient population. Models 
that cannot replicate the complexity of the patient’s unique health experience performed poorly 
(Kansagara et al., 2011) and were sometimes no more powerful than common practitioner sense 
(Damery & Combes, 2017). Thus, PPA could not currently “replace the physician in the process 
of care” (Sniderman et al., 2015).   
It will be important to understand the treatment protocols used by IM providers.  While 
some steps in care may be described broadly across participants, others will be unique to the 
practitioner’s medical practice and only uncovered through deep, qualitative analysis.  The fact 
that application of inaccurate PPA could lead patients/providers to take incorrect next steps 
should be considered.  
II.3      Research Case: Treating Patients with Chronic Pain 
Study design required choosing a medical condition that most IM providers (study 
participants) encountered and would be able to clearly describe. Grounding provider stories in 
one area or patient type would make it easier to compare experiences across the population. 
Also, specific patient and treatment examples would increase “experiential detail, concreteness, 
vividness, and lived-thoroughness” (Van Manen, 2016).  
This research focused on chronic pain because this condition was highly prevalent, highly 
complex to diagnose, presented “an array of adverse health events” (Lin et al., 2017), and could 
be treated in various ways. Chronic pain was officially recognized as pain lasting at least three 
months in the International Classification of Disease (ICD-11) (Treede et al., 2019). This 
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condition either had a primary characterization (pain identified as a separate disease) or 
secondary characterization where chronic pain was a symptom of the “perceived root cause (e.g., 
cancer, surgery, etc.)” (Barke, January 17, 2019). “The three most common diagnostic 
categories” were back pain, psychological disorders, and joint pain, often treated with CAM 
modalities like acupuncture and massage therapy (Pang et al., 2015). Additional description of 
the chronic pain ICD code was included in Appendix E. 
High-impact chronic pain (HICP) was pain experienced for more than 6 months that 
seriously limits quality of life (QOL) (Janevic, McLaughlin, Heapy, Thacker, & Piette, 2017), 
including “worsening health, more difficulty with self-care, and greater health care use” (Grol-
Prokopczyk, 2017). IM practitioners were likely to use the Global Pain Scale (GPS) to 
subjectively measure the level of pain and inform the treatment protocol (Janevic et al., 2017). 
IM providers practicing vitalism focused on improving the patient’s overall QOL, ability to 
perform day-to-day activities, capacity, and mobility versus the simple “elimination of pain” 
(Schneiderhan, Clauw, & Schwenk, 2017).”  
The literature review uncovered the following Health statistics for chronic pain: 
▪ 1 in 5 US adults were estimated to have chronic pain in 2016 (Kuehn, 2018) 
▪ Pain was among the top five reasons patients seek medical attention (Oberg et al., 2015) 
▪ Higher severity of chronic pain (and associated disability) was reported from female, less 
educated, and poorer patients (Grol-Prokopczyk, 2017) (Kuehn, 2018)  
▪ More disability associated with pain was reported amongst African Americans and those in 
the lowest wealth quartile (Janevic et al., 2017) 
▪ Patients sought IM for chronic pain more frequently than any other condition (Horrigan et al., 
2012)  
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▪ Chronic pain costs were “estimated to exceed the costs of heart disease, cancer and diabetes,” 
largely due to impact of chronic postsurgical pain (Katz et al., 2015) 
The prevalence of HICP was impacted by multiple, often overlapping variables like race, gender, 
veteran status, and socio-economic factors. 
Sadly, treatment of chronic pain through the use of opioids led to a public health crisis 
with the U.S. leading other nations in addiction rates (Robinson Country Intelligence Index, 
Georgia State University, 2020). Opioid prescriptions have more than doubled, leading to 
increased “rates of opioid use disorders and overdose deaths” (Bachhuber, Saloner, Cunningham, 
& Barry, 2014). Recently, the large drug manufacturer, the Food and Drug Administration 
mandated Purdue Pharma to shut down business and pay more than $8B USD in fines due to 
their role in the miseducation of the healthcare industry and overlooking the off-brand use and 
misuse of their flagship product OxyContin (Isidore, 2020). A 2017 study of 2,897 patients 
concluded that cannabis which has “efficacy in treating chronic pain” provided “relief on par 
with…other medications, but without the unwanted side effects” (Reiman, Welty, & Solomon, 
2017). The literature identified alternatives to opioids or non-pharmacological means to treat 
chronic pain, including CAM modalities like mindfulness (Dowell, Haegerich, & Chou, 2016) 
(Majeed, Ali, & Sudak, 2018) that IM providers may choose. 
The literature review also produced many categorical reasons why there might not be a 
convergence between IM and PPA for managing patients suffering from chronic pain:   
▪ Complexity of chronic pain treatment protocols may be too high 
▪ Nuance in the IM treatment of Chronic Pain may not lend itself to PPA 
▪ Number of data sources identified may be too high for PPA to accommodate 
▪ There could be overall lack of TTF (fit) when applied to the IM healthcare setting 
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▪ Algorithm aversion amongst IM practitioners may be too high 
The next section addresses the theoretical framework used to explore the primary and 
secondary research questions.  
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III THEORETICAL FRAMEWORK 
III.1 Alternative Conceptualization of Task-Technology Fit (TTF) Theory  
TTF was a golden theory with more than 25 years of application that provided a 
framework for understanding PPA’s future value to IM. TTF emerged in the 1990s in 
Information System (IS) theory as a construct to objectively assess systems based on the end 
user’s evaluation (UE) of the technology (Goodhue, 1995). Technology investment could be 
justified or supported by organizations and managers when there was a “better fit between 
technology functionalities, task requirements, and individual abilities” (Goodhue, 1995). UE 
acted as a surrogate for overall TTF and was measured using survey questions and an agree-
disagree, 7-point, Likert-Type scale (Goodhue, 1995).  
TTF was measured across the following eight factors: quality, locatability, authorization, 
compatibility, ease of use (EOU)/training, production timeliness, systems reliability, and 
relationship with users (Goodhue & Thompson, 1995). Goodhue’s original survey results 
showed that organizational performance (efficiently and effectively executing work/corporate 
goals) increased when TTF was higher. However, high utilization of a “poor system” (with low 
TTF) would have very negative consequences on individuals and organizations (Goodhue & 
Thompson, 1995).  
Another pivotal paper considered fit within different units of analysis (groups and 
individuals). Zigurs and Buckland measured the impact of group support systems (GSS) on team 
performance. While results were mixed, higher fit between technology characteristics and the 
work at hand was proposed as “the most efficient way of dealing with the cognitive load of a 
given task” (Zigurs & Buckland, 1998). Also, the right technology promoting 
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communication/collaboration across a team of users was believed to deliver efficiencies by 
increasing “cohesiveness and conflict resolution” (Zigurs & Buckland, 1998).  
System adoption was impacted by perceived technology EOU, the expectation that 
technology use will require minimal effort, and perceived usefulness (Davis, Bagozzi, & 
Warshawl, 1989). Usefulness was “the prospective user’s subjective probability that using a 
specific application system will increase his or her job performance within an organizational 
context” (Davis et al., 1989). As the complexity or diversity of tasks increased, perceived 
technology EOU reached an upper boundary for predicting TTF (Mathieson & Keil, 1998). We 
would expect various user types to have different levels of technology use (e.g., frequent users 
versus casual users) and require unique functionality to succeed in their roles (Mathieson & Keil, 
1998). Thus, in a complex, Healthcare scenario, an average EOU score across individuals or 
groups handling different tasks would not be a good predictor for fit.  
Shirani et al. used TTF to study the effectiveness of communication tools to impact 
“organizational-decision making,” representing an even higher unit of analysis (Shirani, Tafti, & 
Affisco, 1999). Applied to healthcare this version of TTF would focus on a hospital system or 
department instead of an individual doctor. Task characteristics included “group performance on 
less- and more-structured tasks” with performance measured as the number of ideas generated by 
the team (Shirani et al., 1999). This study also represented an evolution of the theory to consider 
fit across multiple task categories and technologies.  
Goodhue et al. revisited limitations to the theory suggesting UE should be considered 
with caution because of the potential inaccuracies in self-reporting technology utilization 
(Goodhue, Klein, & March, 2000). Howard and Rose also discussed TTF limitations, introducing 
the Task-Technology Misfit (TTM) concept that “Too Little” or “Too Much” functionality could 
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negatively impact “[technology] adoption, performance, and business success” (Howard & Rose, 
2019). These challenges to TTF suggested researchers should take deeper dives into the true 
needs of the people performing the work and then accurately identify technology fit.  
Several studies applied TTF in a Healthcare setting (mostly hospitals), focused on the 
systems used during the MDM process. Chen et al. studied the concept of “leagality” to address 
the elimination of non-value-added tasks “lean” and the ability to quickly respond to changing 
conditions (under time pressure) “agility” (Chen, Yu, & Chen, 2015). TTF was used to 
understand how a computed tomography (CT) patient- referral mechanism served the needs of 
two hospital systems (via a case study) to identify the delta between the As-Is CT system and the 
ideal future state (Chen et al., 2015). 
The literature review only uncovered a few articles about TTF applied to AI tools in 
healthcare. Artificial intelligence-based medical diagnosis support system (AIMDSS) like PPA 
have only been used in practice for a few years at the time of this study (Fan, Liu, Zhu, & 
Pardalos, 2018) and writings about TTF theory peaked in the early 2000’s. Fan et al. surveyed 
202 healthcare professionals and identified six factors other than task and technology 
characteristics that influence the “behavioral intention” or likelihood of adopting AI: personal 
innovativeness, performance expectancy, effort expectancy, propensity to trust (technology), 
initial trust (in the effectiveness of the technology), and social influence (to use the technology) 
(Fan et al., 2018). 
For decades, researchers used TTF to measure current task and technology characteristics 
to measure fit in the current state. Fit was important in healthcare because misdiagnosis and 
medical error introduced and/or caused by technology use literally had life or death 
consequences. However, business transformation and innovation require practitioners to be 
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future-focused; predicting how the healthcare industry, relevant regulations, and emerging (or 
nonexistent) technology may be applied. Due to the exploratory nature of the research question, I 
used a novel theoretical framework called Future-Focused Task-Technology Fit (FFTTF). 
FFTTF explored the gaps between the current and ideal future state to create an 
“understanding of TTF [that guides] practitioners to pair emergent technologies with appropriate 
tasks” (Howard & Rose, 2019). This alternative theory along with “established approaches such 
as design thinking” should be researched together to learn the nuances of what different user 
types expect from using AI-based tools (Maedche et al., 2019). 
III.2 Task Characteristics: IM Decision-Making 
This engaged research sought to prove or disprove if PPA could be used “as a means by 
which goal-oriented individuals perform tasks” (Goodhue & Thompson, 1995). While MDM 
was the primary focus, all five tasks categories in the table below were expected to be described 
by study participants (Zigurs & Buckland, 1998): 
Table 1: IM Task Types (adapted from Zigurs and Buckland, 1998) 
TASK TYPES DESCRIPTION/APPLICATION TO HEALTHCARE 
Simple Tasks ▪ Identifying a single desired outcome without interdependencies 
▪ Filling out questionnaires with historical health data 
Problem Tasks ▪ Finding a single outcome from multiple options 
▪ Choosing between multiple treatment options based on a well understood 
diagnosis 
Decision Tasks ▪ Creating a solution from multiple conflicting options 




▪ Resolving conflict and issues 
▪ Managing iterative communication with a patient who gets worse, 
rejects recommendations, and/or is non-compliant with treatment/ 
medication/interventions 
Fuzzy Tasks ▪ Understanding a highly complex issue 
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▪ Considering information from other providers (e.g., second opinions) to 
diagnose a tough patient 
 
The following PPA use cases (UC) or were identified in the meta-analysis (Oesterreich et 
al., 2020):  
▪ UC1-Planning and Coordination 
▪ UC2-Diagnosing and predicting disease 
▪ UC3-Decision support 
▪ UC4-Risk assessment 
▪ UC5- Reducing readmission [to the hospital] 
▪ UC6-Diagnosing and predicting mental health disorders 
▪ UC7-Health monitoring 
▪ UC 8-Diagnosing and predicting injuries and disorders 
These are task categories within which to apply the technology. Practitioners participating in this 
research (using the IM paradigm) would most likely be focused on diagnosing complex patients, 
maintenance of health, and holistic treatment (Use Cases 1, 2, 3, 4). IM practitioners may also 
consider the mental health implications while treating patients (Use Case 6). Surprisingly, 
preventative health (a goal of IM, CAM, and NM) and recommending alternative treatment 
modalities were not called out as a unique use cases. A phenomenological approach was used to 
gain a deeper understanding of the steps MDM and the task categories performed in IM. 
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III.3 Technology Characteristics: PPA  
The study design also included a unique opportunity for IM practitioners operating inside 
and outside of hospital systems to provide their perspectives on PPA technology. That feedback 
would include perceptions about the functionality, user experience (UE) and other system needs 
or technology characteristics that would theoretically improve the performance of IM 
professionals if they were made available (e.g., future state capabilities). 
There were several PPA capabilities called out in the literature that could be identified as 
technology needs for IM practitioners. Based on Raghupathi’s perspective on Big Data analytics 
in healthcare, users would expect PPA to be “menu-driven, user-friendly and transparent” with 
limited “lag between data collection and processing” (Raghupathi & Raghupathi, 2014). It was 
expected that technology expectations would mirror the eight TTF factors across three 
categories; decision making, operational needs, and responses to the dynamic healthcare 
environment (Goodhue & Thompson, 1995): 
Table 2: TTF Factors Healthcare (adapted from Goodhue and Thompson, 1995) 
TTF FACTORS APPLICATION TO PPA IN HEALTHCARE 
Quality ▪ Access to up-to-date healthcare data and laboratory values at 
the right level of granularity for providers 
▪ Access to accurate calculations, predictions, and 
recommendations based on high-quality data 
Locatability ▪ Relevant patient data, associated metadata, and descriptions 
about the data are easy to find and comprehend 
▪ Navigation to necessary data is intuitive and occurs in a timely 
manner  
Authorization ▪ Rights and roles-based system provides access to appropriate 
PPA modules and functionality 
▪ Providers, case workers, and others only access their subset of 
the data, protecting patient privacy 
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Compatibility ▪ Patient, laboratory, pharmacy, insurance payer, and 
transactional data can be shared and interpreted between 
multiple healthcare systems and surfaced via PPA 
Ease Of Use/Training ▪ Providers have a positive overall perception of the PPA UE 
▪ Initial investment is made to train end users to succeed with 
the technology 
▪ Ongoing refresher training and user support occurs 
Production Timeliness ▪ PPA is accessible for use when needed 
▪ Relevant data is available along the provider’s workflow 
Systems Reliability ▪ PPA performs the expected functions 
▪ Delivery of capabilities supports end users’ needs 
Relationship With Users ▪ PPA is designed with the end user(s) in mind 
▪ Dynamic system supports unique needs of IM providers 
▪ PPA delivers information that supports IM MDM and positive 
patient outcomes 
▪ Feedback loop includes end user groups to influence 
development cycles 
▪ PPA meets healthcare expectations to do no harm to patients  
 
Because predictive and prescriptive analytics tools designed for IM practitioners did not exist at 
the time the research was conducted, study design did not include measurement of the eight TTF 
factors above to determine fit.  
III.4 Impact of Algorithm Aversion on TTF 
Doctors endured many years of training and testing to receive their medical license. Over 
time, their knowledge was honed by real-world experience with patients and ongoing learning. 
Even if the PPA functionality hypothetically met all of an IM practitioner’s needs (e.g., TTF was 
high) and the technology supported the tasks performed, many providers would still reject the 
idea of AI as a supplement or replacement for their intuition and expertise (Dietvorst, Simmons, 
& Massey, 2018). This algorithm aversion (AA) could occur even after providers witnessed the 
system in action or understood that it is consistently more accurate than human judgement. AA 
could especially arise in providers treating HICP patients who may need multiple modalities 
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and/or may never be “cured” of their pain. They may not trust PPA to solve for this level of 
complexity. 
Suryaningrum proposed a new IS model where performance was influenced by TTF and 
actual usage (similar to utilization in other models). TTF influenced three factors that drove the 
individual’s “behavioral intention” for “actual usage” (Suryaningrum, 2012):  
▪ Attitude: perceived usefulness, EOU, and risk of using technology 
▪ Subjective Norm: interpersonal and external influences that shape beliefs 
▪ Perceived Behavioral Control: self-efficacy or confidence to perform tasks, resources to 
perform work, and perception that behaviors are controllable 
In an ideal scenario, healthcare providers would have high behavioral intention with high TTF, 
reducing AA and driving up technology usage and performance (e.g., positive patient outcomes). 
Using the Suryaningrum model, algorithm aversion toward PPA would only decrease 
under five conditions: 
▪ TTF is high (matching the tasks of the end user or group) 
▪ Perceived PPA usefulness and EOU are high 
▪ Perceived risk of using PPA is low 
▪ Subjective norms (value, attitudes, and beliefs) support use of PPA 
▪ IM providers associate PPA use with a gain of efficacy, time, or control 
PPA was not currently designed for or applied to the IM/primary care setting at the time 
of this study, so there was an expectation that most study participants would have limited or no 
understanding of the tech. Even if the PPA functionality hypothetically met the majority of an 
IM practitioner’s needs, it was expected that some study participants would demonstrate 
algorithm aversion (Dietvorst, 2016). Also, there would likely be ethical considerations that 
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would make providers reject recommendations from a PPA tool. We would expect them to show 
algorithm aversion in situations where inaccurate outputs could “severely compromise a specific 
patient’s best interests” (Cohen et al., 2014). The tool may have high TTF, but the data we 
expect to be “benign, neutral, or objective” could negatively influence care decisions by 
surfacing information in a way that introduces bias (Noble, 2018). Or, the PPA outputs (while 
accurate for the test data cases) may not reflect the unique needs of certain patient populations. 
AA could also occur if the system outputs were perceived to be delivered in a “black 
box” where providers receive recommendations without further explanation or the “inner 
workings are not easily scrutinized” (Miner et al., 2014). Doctors would be more apt to use an 
imperfect algorithm if they could perform the following steps (Dietvorst et al., 2018): 
▪ Receive insights into how the algorithm works, interact with the mechanism 
▪ Intervene to alter inputs of the algorithm 
▪ Modify the outputs of PPA based on their patient insights 
The next section includes the Qualitative methods used to address the research question. 
Several considerations were taken when carefully crafting the study design to avoid the 
assumption that providers will automatically adopt PPA technology. 
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IV RESEARCH DESIGN AND METHODOLOGY 
IV.1 Phenomenological Study Design 
A set of rules existed within IM around holistic patient care and the management of many 
treatment modalities and interventions. This code of medical practice would go unseen by someone 
outside of the healthcare profession. A qualitative approach was used to explore the dynamic 
patient-provider relationship and the lesser known “context within which decisions and actions 
[took] place” in this “social community” (Myers, 2019).  
This research was interpretivist in nature, using the phenomenological approach described 
by Creswell to identify the shared human experience of IM practitioners (Creswell & Poth, 2016). 
No assumptions were made during study design that PPA would actually be a fit for IM 
practitioners. So, the methods allowed flexibility to gain a thorough understanding of the task 
characteristics (activities IM practitioners perform), their “lived experiences” while making 
decisions leading to positive patient outcomes (Creswell & Poth, 2016), and insight into the 
technology characteristics (providers’ perceptions about PPA tools). Semi-structured interviews 
included “open-ended questions and dialogue” followed by several, iterative rounds of data 
coding, and classification (Moustakas, 1994). Deeper analysis included horizontalization to 
understand the collective story of all participants and uncover resultant themes (Moustakas, 1994).  
IV.2  Semi-Structured Interview Script 
The semi-structured interviews were split into two sections, Task and Technology. The 
first half of the interview included introductory questions to gain a baseline understanding of the 
participants’ professional background, including their medical licensure, training, and years of 
patient experience. From there, the interview order applied the expectation that phenomenological 
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studies identify what occurs during the patient-physician experience followed by how the patient 
and doctor were impacted by the medical decision making (Moustakas, 1994). The script included 
open-ended questions that identified the following: (1) what providers do when treating patients 
(e.g., task characteristics), (2) how they treat patients holistically, (3) a deeper dive into unique 
steps in IM MDM.  
Questions that identified the textural description or “what” included the following 
(Creswell & Poth, 2016): 
▪ At a high level, please describe your methods when diagnosing a patient with chronic pain. 
▪ At a high level, please describe how you would identify the risk level for patients. 
▪ What are some difficulties/areas of complexity for treating/managing a patient with chronic 
pain? 
This subset of questions was used to populate a list of high-level tasks to explore TTF. The 
next set of questions explored the structural description of the Task (Creswell & Poth, 2016). 
Questions that identified the “how” included:  
▪ How would you describe the integrative MDM process? 
▪ How is a holistic approach to MDM applied to a patient with chronic pain? 
▪ Can you share an example when your intuition/expertise made you reject the standard of care 
or prescribe something other than the gold standard medicine for a patient? 
▪ Please describe the tools/technology you currently use to measure/predict chronic pain patient 
outcomes.  
▪ Please describe the tools/technology you currently use to get recommendations for chronic 
pain patients. 
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The final question allowed the participants to provide more details about what separates 
IM (vitalism and treating the holistic patient) from allopathic medicine (mechanism and managing 
symptoms): 
▪ What is unique about IM that leads to successful patient outcomes? 
Based on the flow of the interview, I asked this question at the beginning or end of the series of 
“how” questions. As needed, the interviews moved off script with additional questions used to 
further investigate the true differentiating factors in IM MDM. 
The second portion of the interview sought provider feedback on the PPA technology 
characteristics and “perceived EOU” (Mathieson & Keil, 1998). Participants viewed three 
screenshots and were given short, spoken descriptions of the data inputs, elements of the user 
interface, and predictive and/or prescriptive outputs. Participants shared any previous experience 
with PPA and a “user evaluation of characteristics” (Goodhue, 1995) by answering the following 
questions:  
▪ What is the extent of your experience with PPA tools?  
▪ What do you like most/least about this tool (overall perception, UE, presentation of 
information)? 
▪ How could these systems be modified to better serve you? What additional inputs/outputs are 
needed? 
▪ What would cause you to doubt the outputs of these types of systems when treating patients 
holistically?   
▪ Can you share a scenario in which your intuition/expertise would make you reject the outputs 
of PPA?  
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▪ Which patient types/MDM scenarios are best supported by these types of tools? Which are 
least suited? Why? 
The final questions were future-focused, asking participants to identify if there should be 
convergence between PPA and IM: 
▪ Should there be a convergence between PPA and IM? Why or why not? 
▪ Which types of decisions could be supported by PPA? Which decisions are inappropriate for 
PPA? 
▪ What is the potential for PPA tools to replace parts of your MDM process? Why or why not? 
▪ How will technology be used to predict and measure patient outcomes and provide 
recommendations in 10 years?  
The full list of questions across both interview sessions was included in Appendix H. 
IV.3 PPA Visualization 
PPATech supported this research by providing screenshots of its proprietary software-as-
a-service platform (SaaS). Their PPA was integrated into hospitals’ EMR to analyze patient data. 
This data included health records, socioeconomic factors and other variables like mobility, 
access to family/community support, and residential stability. The PPA platform used a 
repository of AI algorithms to mimic the MDM processes of medical practitioners.  
The three screenshots were chosen to represent a range of analytics sophistication 
(Davenport & Harris, 2017). The user interface demonstrated three main capabilities:  
▪ Prediction: a display of the patient’s risk or probability of an issue occurring 
▪ Risk Factors: the patient’s clinical and socioeconomic risk factors used by the algorithms  
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▪ Prescription: display of recommendations to medical practitioners (e.g., suggested 
treatments, interventions, and follow up steps based on the patient profile) 
The recommendations/interventions surfaced in the screenshots were based on widely 
adopted guidelines/protocols that were refined and approved by the hospital system that 
implemented the software solution. PPATech believed the ability to perform prescriptive analytics 
was the key factor to speed up and improve the MDM process (and a key differentiator between 
their platform and others on the market).  
There was an assumption that a knowledge gap would exist for the research participants. 
Sharing visualizations during the second half of the interview made it easier to explain the 
following: (1) PPA tools exist and are viable; (2) PPA uses historical patient data to train the 
system algorithms; (3) the patient’s EHR/EMR is used as input to PPA; (4) PPA provides MDM 
capabilities, system functionality, and a unique user experience; and (5) the outputs of PPA are 
patient-specific risk scores, recommendations, and interventions.  
The software vendor’s name was hidden to avoid potential bias. For example, a research 
participant may have been less apt to see the PPA tool as useful or accurate if they did not recognize 
the vendor name and/or it did not match the branded name of their EHR, EMR, or practice 
management system (technology used to schedule patient visits and manage other steps in primary 
care). Finally, all personally identifiable information (PII) that could be used to identify patients 
or providers was redacted from the screenshots. 
IV.3.1 Screenshot 1-Patient Centric View 
The Patient Portal View: Patient Centric View predicted the likelihood across a cohort of 
260 patients of having negative issues within a specific time period. A series of drop-down menus 
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at the top of the screen allowed providers the option to filter the patient population by the following 
categories: 
▪ Cancer type 
▪ Risk level 
▪ Location of the patient (within the hospital setting) 
▪ Insurance Payer type/name 
▪ Provider name 
▪ Whether or not the patient is unmarried/living alone 
Users could also enter text into an open field to search by patient name.  
A list of patients was located in the bottom, left portion of the screen. All PII was hidden 
from participants, covered by a semi-opaque gray square. The row of information associated with 
a patient included  his/her medical record number, date of birth, and name. The PPATech tool 
applied proprietary algorithms against the patient EMR data to calculate a series of risk scores. 
The scores were displayed across seven columns to denote the risk (medium or high) of the patient 
experiencing an issue within a time period: 
▪ 6-month Deterioration 
▪ 6-month Depression 
▪ 30-days ER visit 
▪ 30-Day Mortality 
▪ 30-Day Pain 
▪ Readmission 
At the intersection of a patient row and a condition, the presence of an orange or red circle 
in the cell denoted medium or high risk, respectively. For example, if Patient A had a red circle in 
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the “30-Day Pain” column, they would be at high risk of presenting with a pain episode within 30-
days of the provider viewing the information. Readmission at any time represented negative 
consequences for patients (and resultant cost on healthcare systems), thus did not include a time 
period. Clicking directly on a patient line item would allow the provider to drill down into specific 
risk factors and recommendations (this was not shown or demonstrated in Screenshot 1). 
 
Figure 2: Screenshot 1-Predictive Analytics 
IV.3.2 Screenshot 2-High Risk #1 - 30 Day Mortality 
The Patient Portal View Example: High Risk #1 - 30 Day Mortality presented a view of a 
population of 750 patients ranked by their risk of mortality (death) within 30 days of the provider 
viewing the information. Each unique row included the patient name (redacted), medical record 
number, date of birth, age bracket (e.g., between 61 and 80), client identifier, date added to the list, 
and days on the list. The provider name was also redacted. Finally, each row also showed the 
following relevant information: Insurance payer name, risk percentile (e.g., Top 25), and risk level 
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(e.g., Medium or High). Once a patient was selected from the list, the name was highlighted dark 
blue, the risk level was highlighted light blue, and patient-specific information populated the 
bottom half of the screen. 
The clinical risk factors contributing to the high-risk score were presented in a list at the 
bottom, left portion of the screen. The example showed some laboratory results, a diagnosis history 
of malignant neoplasm, diagnosis history of volume depletion and other factors. Based on the 
number of factors, providers could scroll bar to navigate through this list. Socioeconomic risk 
factors leading to a high-risk score were listed in the bottom, middle portion of the screen. The 
patient example had a high likelihood to lack digital and tech fluency, likely education limited to 
high school, lack of residential stability, low individual income, and low household income. 
Providers could scroll up and down through this list as well. 
The prescriptive interventions were shown in the bottom, right portion of the screen. Based 
on the example patient’s EMR data, clinical and socioeconomic factors; the PPATech algorithm 
created a list of recommendations for the providers to scroll through and consider. A subset of 
the interventions included the following actions:  
▪ Consider reevaluating care plan 
▪ Prepare patient's families/caregivers 
▪ Focus on symptom management and comfort/nausea and vomiting 
▪ Consider mobilizing community support 
System functionality to undo, revert, refresh, or pause actions were not discussed during 
the interview. Also, the ability to share content and download information was not shared with 
study participants. These system features did not differentiate the PPATech user interface from 
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other modern SaaS platforms and their consideration would offer no additional, impactful insights 
about the TTF of PPA. 
 
Figure 3: Screenshot 2-Prescriptive Analytics 
IV.3.3 Screenshot 3-PPA Recommendations/Interventions 
The third screenshot provided a more detailed view into the PPA functionality, showing 
how providers receive patient-specific recommendations. The list of patients was oriented on the 
left half of the screen, including the hospital room number, the patient name, and their risk level 
for sepsis. Selecting a patient from the population of 30 highlighted their row light purple. The 
top of the screen showed their name again, the medical record number, age, gender, hospital 
room (again), facility, unit (e.g., Nurse Unit), the date/time they were admitted, their length of 
stay (LOS) at the hospital, their risk level for sepsis (again), and risk percentile (e.g., Top 
Quartile). 
In the bottom middle portion of the screen the tool listed the clinical and socioeconomic 
risk factors used to determine the patient’s score. Clinical factors included the following:  
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▪ Current Encounter: Benzodiazepines 
▪ Current Encounter: Cardioselective Beta-Blockers 
▪ Current Encounter: Lab Test: Magnesium: Record of Lab Test 
▪ Multiple Chronic Conditions 
The patient’s socioeconomic factors included the following: 
▪ Lack [of] Residential Stability 
▪ Low Likelihood of Internet Commerce 
▪ Lower Commercial Retail Available Nearby 
▪ Single: Likely Without Support From Spouse 
The bottom right portion of the screen listed detailed recommendations and their status. 
The first recommendation was: “Not Started-RN-Review the Micro labs for updated sensitivities. 
MD-Review Micro labs for updated sensitivities and order as indicated.” This naming convention 
designated that for this intervention there were separate steps for a Registered Nurse (RN) and 
Medical Doctor (MD) to complete. 
The provider had the option to consider the recommendations/interventions and update the 
status from a drop-down menu as “Not Started,” “In Progress,” “Completed,” or “Declined.” There 
was also a text field where providers could enter comments to add details and/or explain their 
MDM. The PPATech tool collected this transactional data and the patients’ future outcomes to 
further train the algorithm, allowing the PPA tool to improve over time and become incrementally 
more accurate (ML). 
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Figure 4: Screenshot 3-PPA Recommendations/Interventions 
IV.4 Recruitment Strategy 
After Georgia State University’s institutional review board (IRB) approved the research 
(IRB number 21115), potential participants received a recruitment letter via e-mail (see Appendix 
F). Those messages included the following elements: 
▪ The voluntary nature of the research  
▪ The benefits of the research 
▪ The estimated time investment for participants for 2 interviews 
▪ The ability to opt-out of research at any time 
▪ The need to ensure patient anonymity at all points of the process 
▪ The compensation schedule for the research 
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Unanswered e-mails were followed up with additional rounds of messaging. After the first round 
of interviews, a snow-ball approach was used to reach out to IM professionals within study 
participants’ professional networks.  
Only active U.S. healthcare practitioners were considered for this study. The following 
inclusion criteria was applied when recruiting potential participants: 
▪ Practitioners received proper medical training  
▪ Practitioners practiced/understood the concepts of IM  
▪ Practitioners were actively treating patients presenting with chronic pain    
All research participants reviewed an informed consent form that highlighted the voluntary nature 
of this study (see Appendix G).  
Each participant gave verbal consent before starting the interview. Research participants 
received $40 USD for completing the first interview session and $60 USD for the second session. 
They decided between compensation provided in the form of a gift card or a donation made in 
their name to the non-profit organization of their choice. 
IV.5 Research Participant Descriptive Statistics 
The criterion recruitment strategy (Creswell & Poth, 2016) was used to identify the first 
four participants. They described a diverse community of care providers who supported chronic 
pain patients. The recruitment strategy shifted to identify a cohort with a large mix of medical 
licensure and specialties. Recruitment was stopped after 13 participants. The final number was 
determined after the initial qualitative coding results reached theoretical saturation, consistent 
themes were repeated across participants, and no additional insights were needed to identify the 
“essence” of IM.  
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Recruitment efforts yielded 13 study participants from 11 U.S. states. 62% of study 
participants were women. Their medical licensure included Naturopathic Doctor (ND), Doctor of 
Chiropractic (DC), Medical Doctor (MD), Physician Assistant (PA), and Doctor of Nursing 
Practice (DNP). The shortest professional experience working with patients was two years. The 
longest was 31 years as a practitioner. The median experience across all participants was 9 years. 
Table 3: Study Participants’ Medical Licensure and Experience 






1 ND1 Female MI ND 5 
2 DC1 Male GA DC 8 
3 ND2 Male IL ND 2 
4 MD1 Female OH MD 23 
5 DC2 Male PA DC 2 
6 MD2 Female MI MD 9 
7 MD3 Female MD MD 18 
8 PA1 Female NC PA 12 
9 DNP1 Female MI DNP 12 
10 MD4 Male FL MD 3 
11 PA2 Male OR PA 31 
12 MD5 Female KS MD 9 
13 MD6 Female WI MD 13 
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Participants practiced in diverse medical settings: inpatient hospitals, outpatient primary 
care or family medicine facilities, and specialty practices like Sports Medicine or Chiropractic 
offices (see Figure 4 below). Three providers (PA2, and MD1, and MD6) attended the Andrew 
Weil Center for Integrative Medicine at different points in their careers to gain IM training above 
and beyond their initial medical degrees ("Andrew Weil Center for Integrative Medicine," 2021). 
MD2 and NDP1 practiced medicine and also worked in academia, teaching the next generation 
of practitioners as a Professor of Internal Medicine and Pediatrics and Professor of Nursing, 
respectively. 
 
Figure 5: Study Participants’ Care Setting and PPA Experience 
 
 44 
Eleven providers had medical licensure recognized by their state of practice. While 
medically trained and actively managing patients, ND1 and ND2 operated in Michigan and Illinois, 
respectively, states that did not recognize their ND license at the time of the study. ND1 practiced 
under the medical supervision of an osteopathic doctor which allowed her to write prescriptions or 
“order higher force inventions.” ND2 confirmed that patients seeking alternatives to allopathic 
medicine searched for an MD with “additional training in holistic medicine” or ended up paying 
for IM services out of pocket. And while MD1’s medical license was accepted in the state of Ohio, 
she did not accept any form of medical insurance. She offered a diverse menu of IM services and 
made concessions to help reduce the overall cost to her patients.  
Five providers had previous experience with PPA technology. DNP1, MD2, MD3, and 
MD5 operated in hospital settings where the EMR system had some form of predictive or 
prescriptive analytics add-on functionality. DNP1 described the tool used to predict and track 
hospital readmission: 
“In the hospital, we keep track of congestive heart failure patients…if they keep getting 
readmitted within 30 days, that's a danger for us. That means that we haven't been doing our job 
correctly. We look at…how soon did they get to their primary care provider after we discharged 
them from the hospital? I've used something like this before, not specifically related to pain 
though.”  
MD2 said she hadn’t used PPA but described the Michigan Automated Prescription 
System. This recommendation tool was “linked to EMR” and provided PPA functionality: 
“I can just hit a button and I can get the latest report to see medications that we're going to 
prescribe to my patient. It comes with the prediction scores. If [a score] is extremely high, it'll give 
me a warning. So, I guess I do use some technology to assess my patients' risk. We get a quarterly 
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report from the state of Michigan that will compare our prescribing practices to other physicians 
in the same discipline of medicine…whether we're prescribing more, average, or lower rates than 
others in our locality.” 
PA2 did not have direct experience with PPA but received predictive information (risk of 
readmission scores) from providers at the local hospital to help him care for his patients upon 
release. 
This group treated chronic pain patients using multiple medical specialties and various 
complementary and alternative modalities shown below: 
Table 4: Medical Specialties and CAM Modalities Practiced 




▪ Controlled Substance 
▪ Family Medicine 
▪ Fertility 
▪ Geriatrics 
▪ Integrative Medicine 
▪ Internal Medicine 
▪ Musculoskeletal 
▪ Naturopathic Medicine 
▪ Obesity Management 




▪ Reproductive Health 





▪ Diet Management 
▪ Hydration Management 
▪ Infrared Therapy 
▪ Intermittent Fasting 
▪ Laugh Therapy 
▪ Lifestyle Management 




▪ Sleep Management 
▪ Spirituality 
▪ Topical-Needle Treatment 




MD2 and MD3 were recruited to provide perspective from the fringe of the IM community once 
a patient’s condition was so advanced that they required highly invasive interventions. Both 
participants operated in hospital systems and performed some level of controlled substance 
management. MD3 also performed surgery and managed patients in a specialty practice.  
IV.6 Virtual Interviews and Data Integrity 
There was a social-distancing restriction in place to reduce the spread of infection due to 
Covid-19. Research participants attended WebEx virtual meetings for both interview sessions. 
This allowed practitioners outside of the state of Georgia to participate with no added cost or 
inconvenience. The interviewer worked from a secure office and each healthcare provider took the 
calls from private locations to ensure no patient data was exposed during the process. WebEx 
provided the ability to see the participants, react to non-verbal cues, and discern when follow-up 
questions or additional descriptions of the PPA screenshots were needed. 
The WebEx platform allowed recording of the audio and visual data in one consolidated 
file. Key statements, patient stories and perceptions of PPA were captured by the interviewer in 
real time as written notes on a printed copy of the interview script. A back-up .mp3 audio file was 
created using a digital voice recorder placed near the researcher’s laptop. The TranscribeMe third-
party service provided verbatim transcription of the participants’ audio recordings as a .txt file.  
All audio, visual, and text files were maintained in a secure collaboration space with access limited 
to the researcher and principal investigator (Doctoral Advisor).  
ND1 conducted her interviews on two different days. DC 1 conducted the first session, 
took a 15-minute break, and then finished the second session. Due to the difficulty recruiting busy 
professionals, the approach was changed to conduct  both sessions as one interview with a duration 
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from 1-2 hours. The shortest duration for both sessions was 50:15. The longest duration was 
1:35:44. The average duration across all 13 interviews was 1:13:12. This represented 952 minutes 
of qualitative data to transcribe, code, and analyze. 
IV.7 Data Coding and Classification Methods 
NVivo 12 computer assisted qualitative data analysis software (CAQDAS) was used to 
perform qualitative coding on the transcriptions (Saldaña & Omasta, 2016). Due to the futuristic 
nature of this study, no assumptions were made of how IM practitioners would describe what was 
unique about their method of practice nor how they would react to PPA. Therefore, no researcher-
generated codes were created before data collection.  This content was coded in an iterative fashion 
(see Table 5 below) that allowed for unexpected learning to occur with themes emerging 
organically over time (Saldana, 2011). Once patterns emerged, recoding in NVivo was used to 
create more “straightforward, descriptive label[s]” (Miles & Huberman, 1994). 
Table 5: Iterative Qualitative Data Analysis 
ANALYISIS PROCESS EXAMPLE 
First Cycle 
Coding 
Get accustomed to the IM world, 
jargon, high-level story  
Open Coding Honor the provider’s voice, learn IM 
experience/jargon 
Code line-by-line with short phrase 
“Naturopaths use a health 
model not a disease model” 
Holistic Coding Exploratory-Apply one code to a 
sentence up to a paragraph 
Long medical anecdote coded 
as “Patient Story” 
Jotting and 
Memoing  
Take written notes on each interview, 
initial perceptions 
Identify my original biases 
Identify any newly uncovered biases 
Write small narratives as themes arise 
“Provider was introverted and 
straight to the point. Over the 
course of the interview her 
responses…” 






Code text across all interviews into 6 
coding categories.  
Text can exist across multiple 
categories.  
Example could also be coded to Task 
Characteristics, Future State, Hot 
Quotes, etc. 
Hot Quote: “And so this whole 
idea of treating a diagnosis or a 
symptom as opposed to the 
person, is what we're trying to 
get away from with integrative 
medicine.” 
Subcoding Used when original scheme is too 
broad 
“Screenshot 1” updated to 
“Screenshot 1: Positive, or 
Negative, or Neutral” 





Values Coding Identify provider’s values, beliefs, 
attitudes 
B: “Convergence is inevitable” 
Second Cycle 
Coding 
Finalizing Story for Results, 
Discussion, Conclusion  
Pattern Coding Identify Themes, explanations, 
relationships 
Identify TTF constructs 
Draw out essence of IM 
Address the RQ 
 
The first cycle included open coding, holistic coding, jotting and memoing. Open coding 
allowed the opportunity to understand the medical terminology/jargon used in IM. Each line of 
transcribed data deemed to have value received a separate code using the provider’s verbatim 
language. DC1 asked a patient, "Why don't you go see a primary care physician to get some 
bloodwork done because I think you might have such and such going on?" This was coded as 
“Refer to primary care for bloodwork.” No additional grouping with other codes or attempt to 
induce a theme occurred.  
Providers painted detailed pictures of how they treated complex patients using anonymized 
stories. For example, the following longer anecdote from NP1 was coded holistically as “Patient 
Story:” 
“I had a patient. She…was diagnosed [with] rheumatoid arthritis by another doctor. She 
came to me. She was very young, maybe 24. She presented with pretty severe rheumatoid arthritis 
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in her hands and her knees, and her feet. But then also was having a lot of gastrointestinal concerns 
as well. And so that same doctor/ that had diagnosed her put her on…some sort of a diet that was 
supposed to heal her gut, and it wasn't working. So anyway, we definitely addressed the diet…and 
put her on a more plant-based anti-inflammatory diet, but still reduced carb intake because she had 
some other stuff going on. Then we worked on pain relief specifically. So, I put her on 
supplements…to help reduce pain…things like turmeric. It was a combo supplement if I remember 
correctly. And so anyway, she left. She came back a month later. No change in her pain 
whatsoever. So, I kind of had to go back to the drawing board.” 
After holistic coding, recoding was performed to break large paragraphs into smaller 
chunks. A portion was recoded to “Patient Presented with Multiple Issues.” Then the text 
describing the separate steps conducted by NP1 received codes: “Manage Diet,” “Prescribe 
Supplements,” and “Reconsider Treatment.” This growing list of codes was compared to the 
original jotting, notes taken on paper during the interviews, to ensure the participant’s complete 
story was captured.  
Memoing in the NVivo tool allowed initial perceptions about the provider’s style and 
background to be captured while still fresh. Additional memos included key statements made by 
participants and feedback used to improve the flow of the interview sessions. NP2 had less 
experience than others but provided a very thorough explanation of his process/tasks. His memos 
gave a roadmap for additional consideration during coding: 
▪ NP2 performs many tasks; he practices psychology as well (mental component of health) 
▪ The patients' QOL measures are important: this is called center of gravity, what they care about 
(e.g., holding or playing with their grandkids) 
▪ IM uses a multi-organ approach which is the opposite of the way PPA was created 
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▪ There is a juxtaposition in how he practices and PPA’s design (using a health model versus the 
disease model) 
▪ The trend of patients choosing IM will create an uphill battle for PPA adoption 
Memos captured after the NP2 interview prompted an update to the interview script format, 
adding three separate line items for the PPA question 2: “What do you like most/least about this 
tool (overall perception, UE, presentation of information)?” Stopping to ask the same question 
again for each screenshot created natural pauses in the script and made it easier to jot notes for the 
positive, neutral, and negative perceptions in the separate sections for each technology 
visualization. It also made it more obvious when the discussion around either of the three 
screenshots was truly exhausted. Finally, original researcher biases and any newly uncovered ones 
were recorded as memos. These biases (many created from professional experiences with 
healthcare providers) were noted in the Discussion section because they provided the mental and 
emotional framework within which I experienced or learned about the IM phenomenon (Creswell 
& Poth, 2016).  
 51 
V ANALYSIS AND RESULTS 
Analysis of the 13 interviews created a wealth of qualitative data: descriptions of 
integrative medical practice, perceptions of the PPA screenshots, thoughts on the future 
convergence of IM and PPA, and real-world experiences with patients suffering from chronic pain 
(and other conditions). Participants described the many steps they took to improve patient 
outcomes in the first half of the interview. A high-level task list was captured as written notes on 
the printed interview script. During the second half of the interview, each task was read back 
individually, and participants were asked how the system could be modified to support their ways 
of working. For example, DNP1 explained the importance of referrals: 
“I usually have my people with chronic pain referred to a pain specialist because in those 
visits the pain specialist has time to locate different modalities of pain control, not just 
medication…I will still end up referring them…because the pain specialist usually is the one that 
will order those scans and then be able to move on those results…if there's a neurological problem 
or issue.” 
“Refer to a pain specialist” was captured as the note. In the second half of the interview, DNP1 
was asked: 
“How could the systems be modified to help you manage referrals to the multiple 
specialists that you might refer someone to?” 
She described how PPA could support this task: 
“And I'm not the expert on the resources in the community, that's what my social worker 
does. But I may be able to say, "Refer to social worker", and it goes directly to her notifications. 
And she can make the phone calls or follow up with whatever the psychosocial needs are. So, this 
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can be a system where…this can be flagged to them...You flagged it to the specialist that's able to 
follow up…if you're not able to…on your visit.” 
Her answer moved past the original explanation of referral to a pain specialist, mentioning 
the importance of connecting social workers as well. She imagined how future state PPATech 
workflow could “flag” or send alerts to other members of the care community. Similar questions 
were asked in a stepwise fashion until all high-level tasks identified in the first half of the interview 
were discussed.  
In some situations, multiple tasks were combined into one high-level task. MD6 showed 
concern about “the many social-economical barriers that may prevent certain patients from getting 
the help that they need in order to appropriately treat their pain.” Her examples, including lack of 
financial means, insurance issues, and lack of access to healthy foods, were aggregated to the 
following simplified question: “You identified barriers to access to care. How could these PPA 
tools support that part of your process?” This approach of reading back the identified tasks 
increased continuity across the two interview sessions and helped participants identify fit within 
the context of real processes/workflows they performed.  
The final code set included the following categories: Provider Background, Patient Stories, 
Impactful Quotes, Task Characteristics, Technology Characteristics, and TTF (Ideal Future State). 
This coding schema also included several subcodes (see Appendix I). 
V.1 Task: IM MDM 
During the first half of the interview practitioners articulated 102 high-level tasks that were 
documented as written notes (see Table J1 in Appendix). During deeper analysis of the transcripts, 
309 unique IM tasks were coded across all participants (see Table J2 in Appendix). They were 
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split into textural and structural task types. The data was then distilled to create a mutually 
exclusive and comprehensively exhaustive list grouped by task category as shown in Table 6.  
Table 6: Textural and Structural Description of IM Phenomenon 
TEXTURAL  DESCRIPTION: WHAT PROVIDERS DO 
Perform Intake/ 
Assessment 
▪ Assess patient, Record psychosocial functions, Track 
parasympathetic factors 
▪ Take patient medical history, family history, prescription & 
controlled substance history, previous surgeries 
▪ Record results of 1 to 3-hour assessment, clinical evaluation 
and physical exam, SOAP Notes (Subjective, Objective, 
Assessment, Plan) 
▪ Perform physical exam, Collect vital signs and biometrics 
▪ Perform mental health screening questionnaires, Conduct 
safety assessments to identify red flags 
▪ Perform acute crisis stabilization (disposition planning) 
▪ Perform physiological, neurological, & chiropractic assessment 
▪ Request and view previous records 
▪ Conduct Functional Screening, Conduct Orthopedic Tests 
▪ Order a food panel and analyze results 
▪ Order advanced imaging/x-rays/ultrasound and analyze results 
Make/ Update 
Diagnosis 
▪ Review Test Results, Analyze comorbidities 
▪ Follow risk models based on specialist protocols 
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▪ Record diagnosis 
▪ Reassess original diagnosis (including from another provider) 
Create/Manage 
Treatment Plan 
▪ Interview patient to align on a care plan and/or pain contract 
and/or psychiatric medication treatment plan 
▪ Track diet and gut rest (intermittent fasting), manage water 
intake 
▪ Track complexity using provider-specific spreadsheets, Record 
matrix of CAM modalities and outcomes over time 
▪ Record notes about impact of antipsychotic meds, track 
concomitant medication data and physical symptoms 
▪ Follow state guidelines for controlled substance management 
▪ Order additional genetic testing, laboratory tests, bloodwork 
and analyze results, monitor metabolic deficiency 
▪ Track compliance to care plans, morphine dose equivalence, 
and changes to plans over time 
Engage Care 
Community / Manage 
Administration 
▪ Manage referrals and flag bad providers 
▪ Manage disability application paperwork and process 
▪ Interact with state Medicare system for opioid misuse 
Manage Ongoing 
Education 
▪ Communicate CAM options with patients 
▪ Educate patients about holistic medicine, Share 
homework/research topics 
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▪ Receive education on additional modalities, articles, 
guidelines, perform independent research on IM websites, 
attend conferences 
STRUCTURAL DESCRIPTION: HOW PROVIDERS DO IT 
Holistically ▪ Treat Holistically (Mind, Body, Spirit), Support multi-organ 
approach 
▪ Use talk therapy to track patient to resolution 
▪ Monitor daily habits, sleep, behaviors and lifestyle 
modifications 
Gradually ▪ Take a gradual approach, Track stepwise recommendations, 
patient story and results 
Using Objective & 
Subjective Data 
▪ Identify “center of gravity” (objective and subjective goals) 
▪ Record subjective measures, PRO like pain scale  
Within Care 
Community 
▪ Manage ecosystem of providers, specialists, naturopaths, 
mental health, pain specialists, case managers, social workers  
▪ Communicate about patient progress and collaborate on 
dynamic care plan 
While Empowering 
Patients 
▪ Provide immediate feedback to patients 
▪ Help patients associate changes to QOL using gamification 
▪ Track patient trust level 
 
The first textural task in the IM process was to perform intake. The intake process was 
consistently described as a lengthy interview in which the provider collected patient history, family 
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history, and an understanding of the patient’s expectations for reducing or eliminating chronic 
pain. This initial consultation ranged from 30 minutes to 3 hours and was more exhaustive than 
the standard 15-minute appointments of the allopathic medicine experience. ND1 also described 
the “need to kind of press [patients] on some of those bits of information” to ensure the initial 
assessment was as complete as possible. 
Based on the provider’s specialty, multiple types of assessments were performed, including 
physical exams, functional screening, orthopedic tests, and food panels. Many providers (e.g., 
Chiropractors, Sports Medicine, etc.) conducted hands-on assessments of the patients’ range of 
motion. DC2 boasted, “the only tools we use are right here, our hands. We see how you move.” 
PA1 and MD4 performed mental health screening questionnaires and conducted safety 
assessments to identify red flags that may lead to serious issues like suicide or doing physical harm 
to others. In some cases, they performed acute crisis stabilization for patients presenting at the 
hospital under duress (e.g., next steps for a bipolar patient presenting in a manic state). Disposition 
planning determined if the patient could be released under their own recognizance or if they needed 
to be committed to a mental health facility.  
All providers ordered x-rays, ultrasounds, and/or another type of advanced imaging to 
confirm their original assessment or continue root cause analysis. Providers used a systematic 
process to analyze the imaging data along with the output of the intake process, other test results, 
medical training, and their own expertise/intuition to make/update diagnosis. In some cases they 
reassessed the initial diagnosis received from the patient’s previous care provider. ND1 explained 
this collaboration process and the need to communicate with other doctors with a level of humility 
(e.g., not assuming a superior stance): 
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“I'm never going to step on another doctor's toes because we are using an integrative 
approach even if I don't think it is the right [diagnosis]. Like I said, it's better to rule things out 
than to just ignore their perspective.” 
Collaboration amongst primary care and specialists was necessary due to the complexity of treating 
the HICP and chronic pain population and the multitude of factors contributing to the underlying 
diagnoses.  
The diagnosis and understanding of patient expectations was used to create/manage a 
treatment plan which included multiple components:  
▪ A pain contract and/or psychiatric medication treatment plan 
▪ Prescription of pharmaceuticals, medical devices, supplements, botanicals, and other options 
▪ Expectations and documented plans for diet, fasting, and hydration 
▪ A plan for improving lifestyle, sleep, and other contributing behaviors 
The dynamic treatment plans were expected to change over time with input from the 
provider, patient, and extended care community. ND1 described the need to identify objective and 
subjective factors (including personal goals) to inform the treatment plan: 
“We always try to find the center of gravity. So, let's say I'm dealing with a patient who's 
been having some kind of toxic exposure and that usually creates a plethora of issues later on 
metabolically while they may have immediate concerns that are more troubling to them. So, it 
might be something as simple as, ‘I want to be able to hold my grandchildren again, and now I 
have this pain in my arms and I can't do it.’ That's critically important to them. I take a 
whiteboard…and I will map out everything that is going on with them, what systems I think are 
the most affected…which ones I think are most problematic, which ones can kind of intertwine 
and be addressed at the same time.”  
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Providers documented plans and the patient outcomes over time in EMR systems, on paper, or 
with spreadsheets that captured a unique set of health determinants. MD1 created a proprietary 
tracker that allowed her to “follow their subjective pain levels every three months to see how much 
and how quickly they get better.” 
Providers engaged a care community to manage chronic pain patients. The referral process 
was not always straightforward as there were blind spots in which providers could deliver CAM 
options. Also, participants needed to flag “bad providers” that had unsavory reputations. MD 3 
called out her discomfort working with chiropractors: “I'm not a huge fan of chiropractors because 
of a couple of bad experiences that patients have had, especially when it deals with the neck.” 
Some providers described discomfort referring patients to naturopaths, potentially due to lack of 
understanding of how they practice medicine. While all IM providers demonstrated a willingness 
to work within the community of care, some demonstrated unease with the limited nature of the 
care provided in the allopathic setting. DC2 further expanded the view of the care community to 
include the patient’s family/support system. 
Additional administration was necessary to manage the overall care process, ensure 
compliance with the patient contract, and track prescription of controlled substances in accordance 
with state regulations. MD2 described the regulatory process: 
“The Michigan Automated Prescribing System…will show all controlled substances that have 
been prescribed by any physician in the state. If the patient's story aligns with what I see in the 
MAPS system, then it makes it a lot easier for my barriers to come down to actually believe exactly 
what they're telling me.” 
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Based on degradation of a patient’s QOL, providers also managed the disability application 
paperwork for their state government and the iterative process to receive and maintain benefits 
(e.g., secure reimbursement and vouchers to reduce the cost for medical service). 
The final textural task category was to manage ongoing education. Providers introduced 
new modalities to patients in an iterative fashion, educating them on the link between action taken 
and positive outcomes. Topics like holistic medicine, spiritual components of health, and the value 
of CAM options required providers to create “homework” so patients and their families could learn 
at their own pace. Providers also conducted their own self-study, proactively researching treatment 
and medication options via IM websites, medical journals, published industry-accepted guidelines, 
and at conferences. 
Analysis of the structural task categories (e.g., how providers make decisions to improve 
patient outcomes) uncovered five major themes. IM requires practitioners to: 
▪ Treat holistically (the mind, body, and spirit), supporting a multi-organ approach; 
▪ Suggesting changes gradually, tracking recommendations over time;  
▪ Using objective and subjective data with understanding of the patient’s goals; 
▪ Communicating patient progress within the care community, collaborating on the dynamic 
care plan; 
▪ While empowering patients to learn about health, gaining trust in their provider. 
The structural task list exposed anecdotal differences (and additional modalities) that make IM 
unique from allopathic medicine. Study participants identified 57 IM and Allopathic Medicine 
Comparisons (see Table J3 in Appendix).  
DNP1 used an interdisciplinary approach to practice holistic medicine:  
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“So, somebody's telling me they have chronic pain. Then I'm getting the pain specialist on 
board. I'm asking questions about mental health to just make sure that there's no underlying 
depression or something else that's masking something else. I'm giving them physical therapy, not 
just throwing a pill at the situation.” 
She used the underlying patient needs to build a unique care community. DNP1 also explained the 
reality that patients often need additional mental health care and comforting after receiving 
unexpected or bad news: “they're in my office crying, snot and tears because of this diagnosis and 
they can't really wrap their mind around it.” 
DNP1 And MD5 both mentioned the iterative nature of educating patients about realistic 
outcomes and treatment options. DNP1 candidly told patients “if you are looking for no pain, that's 
may not be a realistic expectation for you. So now we [have] to talk about what's a tolerable pain 
level.” MD5 described many examples of dietary changes having a better effect than medications 
prescribed through a purely allopathic approach. She used a series of questions to challenge her 
patients and educate them on the benefits of “intermittent fasting” and “gut rest.” 
Building a trust-based relationship was described as a prerequisite to better 
communications with patients; which is key for empowering people to learn on their own and 
make better health decisions. MD3 explained how her mannerisms eased tension and help establish 
better relationships: 
“I never wore a white coat. I wore scrubs and a shirt…I don't use big words. And it's sort 
of like just going to your friend's house to talk about your problem. And so that was my approach 
to things. I'm silly…my whole goal is to make things comfortable. You have to have just a lighter 
touch…when you treat patients…because they have to trust you.” 
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PA1 boldly claimed "integrative medicine…should be the way of the world. What we've 
been doing in our healthcare system up till now has not worked.” PA2 provided a powerful 
clarification that while different from allopathic medicine in practice, IM is still evidence-based at 
its core: “IM does not blindly accept CAM therapies just because they are complementary and 
alternative. They have to be strongly supported by science and evidence.” This was confirmed by 
ND2 who joked, “what’s the naturopathic treatment for appendicitis? Surgery…it’s the same 
standard of care that we [IM providers] apply to ourselves.”  
V.1.1 Phenomenological Storyboard 
After describing their tasks, participants were challenged to describe the IM phenomenon 
more deeply: “If you had to choose one element or the essence in how you practice, what is that 
one thing that leads to successful patient outcomes?” Horizontalization across their responses was 
captured in a table of 13 IM essence statements:  
Table 7: Horizontalization of IM Essence Statements 
PARTICIPANT HORIZONTALIZATION OF IM ESSENCE STATEMENTS 
ND 1 ▪ Individual patient's perspective needs to be carefully considered 
DC 1 ▪ Grander vision of health respects the “innate intelligence of the body” 
to heal itself once interferences are removed 
ND 2 ▪ Don't view the patient as broken or view the disease; see them as a 
person (humanity) 
MD 1 ▪ Individuality requires goal of healing the whole person, so they no 
longer need the doctor 
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DC 2 ▪ Dive into the root cause analysis (beyond the symptoms) 
MD 2 ▪ The Patient is in control (central theme) 
MD 3  ▪ “The human element” is the provider presenting themselves as a 
human, relatable with fragility 
PA 1 ▪ A provider must be passionate to identify the “day in the life” of a 
patient in order to provide individualized care 
DNP 1 ▪ Act as the conductor to direct patients to the specialist/modality they 
need 
MD 4 ▪ Active listening to build strength of the therapeutic alliance, 
understand patient's perspective 
PA 2 ▪ Overcome the challenges of appointment time to build patient's trust 
in the full menu (conventional and CAM options) 
MD 5 ▪ Empower the patient by consistently asking for their feedback on the 
care plan 
MD 6 ▪ Invest Time! Avoid the assembly line reality of allopathic medicine 
 
The tasks were added to a phenomenological storyboard, a visualization that allows 
researchers to arrange ideas/tasks/themes in a logical and temporal order. Medical care occurred 
in an iterative fashion with many levels of overlap (e.g., a patient may receive a new diagnosis 
after referral to a specialist, causing the need to update the dynamic care plan). However, for the 
purpose of phenomenological storyboarding high-level task categories were used as temporal 
anchors. “Intake/Assessment” occurred at the beginning; “Diagnosis, Treatment Plan, Care 
Community” represented the iterative, middle step; and “path to wellness” was the end goal. Then, 
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the phenomenon was split across these three stages, establishing an easy-to-consume chronology 
shown below (Creswell & Poth, 2016). 
 
Figure 6: Phenomenological Storyboard 
The storyboarding process occurred in an iterative fashion (see Figure J1 in Appendix), 
allowing repositioning of the essence statements until they fit cleanly within the IM MDM 
chronology. Where appropriate, related statements overlapped to show relationships. For example, 
to build trust (purple bubble) providers had to invest time (blue bubble). Each mutually exclusive 
and comprehensively exhaustive set of essence statements were then described with subthemes. 
The central theme that resonated throughout the interviews, analysis and coding process was 
highlighted in the statement: “the patient is in control.” The final storyboard told a clear IM story 
used to develop the phenomenological essence statement. 
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V.2  Technology: Perceptions of PPA 
Each PPA screenshot was described to providers in detail and they responded with their 
perception of the overall tool, UE, and presentation of information (e.g., what they liked most and 
least about each of the three visualizations). 183 technology perceptions were captured (see Table 
J4 in Appendix). The table below included the positive, neutral, and negative gut reactions. 





PERCEPTION OF PPA, UE, PRESENTATION 
OF INFORMATION 
1 POSITIVE ▪ Reminders about patient risk categories help 
providers avoid failure, catch things they may 
have missed 
▪ EOU: the ability to filter the patient list and view 
someone’s risks organized across one row 
▪ “I think it captures some of the pertinent 
information that we need to know.” (MD3) 
1 NEUTRAL ▪ Described as busy, containing too much 
information: “It's not bad. It's a little clunky.” 
(ND1) 
▪ “If you have any basic understanding of layout 
and charts, you should be able to navigate and 
see what their risk is.” (ND2) 
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▪ More context is needed: “I would want to know 
exactly how they evaluate these risk factors.” 
(DC2) 
1 NEGATIVE ▪ Orange and red risk icons: “I probably would 
make the colors a little bit more distinct…the 
contrast isn't great enough” (MD1) 
▪ Black box presentation of predictions (with 
limited supporting information) doesn’t support 
individualized care 
▪ Sharing predictions with patients may skew their 
belief and actually lead to negative outcomes 
2 POSITIVE ▪ Consistently described as more pleasant view 
than Screenshot 1, supporting intake, replacing 
need to review medical documentation 
▪ Summarizes a large amount of data to select the 
correct intervention, including valuable clinical 
and socio-economic risk factors 
▪ Provides insight on patient’s lifestyle, allowing 
provider to change how interventions, access to 
care, resources are shared  
2 NEUTRAL ▪ Doesn’t take into account patient presentation, 
how they are feeling, subjective measures in real 
time 
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▪ “I think the layout of it all is fine.” (PA1) 
▪ Has value if the care community has access and 
data entry is completed in a timely manner 
2 NEGATIVE ▪ Provider’s may be biased by the presentation of 
socio-economic risk factors, negatively 
impacting care 
▪ User interface needs update: “It looks like you 
just typed it on Word and plugged it in there. It's 
just black and white with no spice.” (MD3) 
▪ “I would have liked to see more of a trend in their 
experience, and what has already been done for 
them as it relates to these issues.” (DNP1) 
3 POSITIVE ▪ Consistently described as more pleasant view 
than Screenshot 1 & 2, clear 
organization/grouping of large amount of patient 
data 
▪ Capturing the status of a recommendation 
provides valuable process/workflow information 
to providers 
▪ Capturing status makes it easier to hold providers 
accountable for clinical decisions 
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3 NEUTRAL ▪ Comparing intervention status and downstream 
outcomes will allow for ML and stronger PPA 
over time 
▪ “It does come across as a little bit busy.” (PA1) 
▪ Purple color template consistently described as 
better than Screenshot 1, but slightly difficult to 
differentiate information on the screen 
3 NEGATIVE ▪ Lack of transparency into how the factors impact 
risk score, inability to drill down into a factor 
and/or remove a factor 
▪ Lack of transparency into the timeliness of 
assessments/test results and their interpretation 
by other providers 
▪ “This is not tailored towards an alternative health 
care practitioner like us or an acupuncturist for 
that matter.” (DC1) 
 
V.2.1 Healthcare Scenarios Best Supported by PPA 
Participants identified 21 Healthcare scenarios best supported by PPA (see Table J5 in 
Appendix). The most consistent positive attribute was PPA’s ability to surface a large amount of 
patient data quickly. Instead of needing to seek information from multiple charts and/or systems, 
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providers could quickly view a patient’s story on one screen. MD2 described PPA’s ability to add 
efficiency to the MDM process:  
“Most [tools] just tell you people's risks, and then you have to figure out the intervention 
on your own, and you don't necessarily have time to do that with the number of patients you have 
to see. Listing some interventions that may be helpful, that's key to us actually doing a better job. 
So that's my favorite part of this.” 
This ability to aggregate and surface data was described as a key to IM MDM efficiency. 
DNP1 felt these tools best supported providers who had less awareness of the 
contributing factors to health issues and/or those treating patients who had one, well understood 
condition like diabetes. ND1 confirmed that PPA was least suited for “subjective” issues like 
pain and most appropriate for disease states with a relatively straightforward paths to diagnosis. 
In those scenarios, PPA would mimic the documented standards adopted by the medical 
industry:  
“I honestly don't know if this sort of tool would be as great for pain. But in the case of more 
chronic or somewhat emergent conditions, so like heart disease or diabetes or things of that nature 
where it kind of is what it is. Like if you're insulin resistant and your cells aren't responding, that 
is what it is. You are at higher risk for diabetes…or if you do have vascular sclerosis or a family 
history of heart disease, you are at a higher risk for developing it yourself. Those types of diseases, 
I think this is more beneficial for.” 
MD6 also confirmed that PPA was best suited for a subset of disease states:  
“Heart disease, that would be a good one, congestive heart failure, if it's hypertension, if 
it's diabetes. All of those common chronic diseases where we have so many tools already out 
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there that help us to determine what is the best course of action and treatment. So, I would be 
trustful…because that's been known for a long time.” 
ND2 stated, “if I was in more of an emergency situation scenario, then [PPA] might be more 
helpful.”  
PA1 negated the idea that PPA was best suited for well-known chronic diseases. She 
believed PPA had more value for complicated scenarios in which more information could 
potentially lead to better patient outcomes: 
“So complex patients, patients with several comorbidities, patients that…are facing 
health disparities for whatever reason, a lot of the socioeconomic factors and barriers in health 
care…education. These are the patients that are kind of falling through the cracks and that we're 
missing and we're not supporting enough.” 
MD4 also felt PPA was best suited for complex patients. The system would help providers consider 
questions or treatment protocols they may not often think about: 
“I think it can be useful, especially with patients that present with multiple medical 
comorbidities, which can cause their treatment plan to get a little messy. Yeah, I think this can be 
useful as far as helping any provider to remember any aspects of the treatment plan that they may 
have otherwise missed or did not remember at the moment.” 
The current limitations of PPA shown below far outweighed the best fit scenarios (or positive 
perception of PPA). 
V.2.2 Current Limitations of PPA 
Due to the nature of the interview script, participants provided perception of PPA based on 
the “best-case scenario” or with assumption that the system worked. However, IM providers 
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identified 54 current limitations that would make PPA unsuitable for the way they practice 
medicine (see Table J6 in the Appendix). The majority of their doubts fit into four categories:  
1. Doubt caused by allopathic nature of PPA (not considering holistic and subjective factors) 
2. Doubt about PPA’s ability to accurately predict for a unique, complex patient 
3. Doubt caused by lack of user visibility into how the system/algorithm works 
4. Doubt caused by lack of patient input in system design; no feedback loop in system outputs 
Providers were skeptical of PPA because the outputs were delivered without explanation (e.g., in 
a “black box”). Also, the inability for providers and patients to weigh in on the 
predictions/recommendations or change the weighting of clinical or socioeconomic factors was 
seen as a major limitation. 
MD4 described PPA limitations to support his psychiatric practice: “A lot of the mental 
health evaluation involves communication. And because most of communication is 
nonverbal…there's really no way a computer-based algorithm is going to be able to account for 
[that].” Also, DNP1 uncovered another limitation in PPA’s access to patient records: 
“Mental health, their records are…sealed for privacy reasons. You really don't get any 
information from that visit unless the patient tells you what was discussed or what they're working 
on.” 
PA2 and MD2 felt PPA may not be feasible for patients who require a surrogate “who’s 
making decisions for [them]” or need an interpreter. Ensuring proper data entry in those scenarios 
would require more time than usually available during primary care visits. MD5 exposed how PPA 
would not work for her unique patient populations: 
“If we plug a laboring pregnant patient into that model…they're all going to screen positive 
for potential sepsis because all of them are tachycardic. Most of the pregnant women on labor and 
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delivery would screen positive for sepsis just at a baseline…So I think it's important to make sure 
that the screening systems are adjusted…to make sure that your patient actually fits the algorithm 
that's being used.” 
DNP1 described other barriers to care that PPA may not currently address in their 
algorithms: “psychosocial or social economic issues,” being underinsured, limited access to 
medications, homelessness, and other needs that are handled by social workers and case managers. 
Those barriers would negatively skew a patient’s ability to beat chronic pain regardless of their 
PPA predictive scores. 
V.3 Future IM and PPA Convergence 
This future-focused research challenged providers to think ten years out and consider if 
PPA will one day be applied to IM practice. Participants identified 70 values, attitudes, and 
beliefs toward PPA (see Table J7 in Appendix). The table below highlights their attitudes toward 
PPA (positive, neutral, or negative), their expectation on future convergence between IM and 
PPA (Yes, Maybe, or No), and key beliefs about PPA.  
Table 9: Perceptions Toward IM and PPA Convergence 
PARTICIPANT ATTITUDE  
TOWARD PPA 
WILL IM &  
PPA CONVERGE? 
IM PROVIDER BELIEFS 
ABOUT PPA 
ND 1 NEUTRAL YES ▪ PPA needs overhaul for 
application to NM 
DC 1 NEGATIVE MAYBE ▪ PPA is potentially 
dangerous due to 
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negative impact of data 
inaccuracy 
ND 2 NEUTRAL MAYBE ▪ PPA is impractical for 
managing holistic 
nature of NM 
MD 1 NEGATIVE YES ▪ PPA is detrimental for 
IM if it doesn’t support 
individualized care 
DC 2 NEUTRAL YES ▪ PPA is irrelevant for 
providers who use 
“hands-on” physical 
assessments 
MD 2 POSITIVE YES ▪ PPA is more accurate 
than human intelligence 
MD 3  POSITIVE YES ▪ PPA identifies options 
providers may miss and 
can track the care plan 
over time 
PA 1 NEUTRAL YES ▪ PPA will take >10 years 
of technology evolution 
to properly support IM 
DNP 1 NEGATIVE MAYBE ▪ PPA raises awareness of 




MD 4 NEUTRAL YES ▪ PPA doesn’t measure 
subjective factors and is 
unfit for mental health 
providers  
PA 2 NEUTRAL YES ▪ PPA needs refinement 
to explain “why” 
recommendations are 
provided 
MD 5 NEUTRAL MAYBE ▪ PPA doesn’t consider 
PRO or complexity of 
real-time data 
MD 6 POSITIVE YES ▪ PPA is best fit for 




Amongst the five providers with some PPA experience, the only two who viewed the 
technology positively worked in a hospital setting where the use of EMR and PPA was 
mandated. They both believed systems designed for allopathic care are more easily adopted by 
hospitalists and/or providers who perform more invasive steps like mental health crisis 
stabilization, controlled substance management, emergency care, and surgery. While only three 
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providers had positive attitudes about the use of PPA, the belief that convergence would 
eventually occur was unanimous across study participants 
DNP1 was the only provider with previous PPA experience who viewed the tool in a 
negative light. She felt dependence on these tools could erode critical thinking skills and/or 
remove autonomy from providers over time:  
“I don't want it to get to a point where [PPA] is taking the discernment…the ability for 
the provider to think outside of the box and to really holistically look at the situation because 
they're relying on this.” 
And MD1 felt that regardless of functionality PPA was totally unfit for IM practice: 
“It's very impersonal. I think that this is the problem with medicine today…people are 
trying to put patients into a diagnostic pigeonhole, and that's why they're not getting better. Because 
it just doesn't work that way. I mean, there's not one person that's the same as the next person. And 
so, this whole idea of treating a diagnosis or a symptom as opposed to the person, is what we're 
trying to get away from with integrative medicine.” 
Even providers like MD4 who positively described the presentation of a complete patient 
snapshot did not feel PPA added value above and beyond his own intuition/expertise: 
“[PPA] probably wouldn't be something that I would need at the moment. Don't mean to toot my 
own horn, but I feel like I've gotten pretty good at doing a safety risk assessment… recognizing if 
someone needs to go to the hospital or not.” 
And even when considering a future state system with high TTF, DC1 believed the “human 
element” of introducing error and chaos would still occur. Regardless of their values, attitudes, 
and beliefs toward current state PPA, all practitioners identified many changes or future state 
requirements needed for the emerging technology to fit their ways of working. 
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V.3.1 Proposed Modifications to PPA 
Providers proposed 133 modifications to PPA, including additional data inputs & outputs 
(see Table J8 in Appendix). For PPA to be applied to IM in the future, the PPATech system needed 
to meet the textural and structural tasks identified in the first half of the interviews. This required 
the system be integrated with EMR/EHR and mirror their functionality: allow for data input, 
analysis, and reporting. Three major areas of PPA innovation emerged, shown below as 
capabilities (desired outcome for IM MDM) and functionality (desired tasks performed by PPA): 
Table 10: Three Major Categories of PPA Innovation 
FUTURE PPA CAPABILITY FUTURE PPA FUNCTIONALITY 
Surface Healthcare Big Data ▪ Effectively and securely surface historical and real-time 
data from multiple sources across the community care, 
state systems, Medicare, EMR/EHR, ePRO systems, etc. 
Center Around the Patient ▪ Surface a list of allopathic and CAM referral options; 
support bi-directional communication and collaboration 
on the patient care plan across the community of care 
Measure Path to Wellness ▪ Track a dynamic care plan with “center of gravity” or 
QOL goals, objective and subjective clinical factors, and 
patient input/feedback clearly identified 
 
Participants described the need for multiple data types (historical information, EMR/EHR 
data, real-time patient data) to be made available in one future-state system. DNP1 believed over 
time PPA would become a “connected system, where my clinic, your hospital, a competitor 
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hospital…somewhere where I can go and quickly get the information [on] the patient in my office 
right now.” MD2 added that IM providers should have quick access to patient screening 
information via a connected app.  
Providers widely believed the future state technology should adopt a patient-centered 
approach. DNP1, MD2, and MD3 mentioned that patients should have access to their records and 
perform data entry at home, requiring internet and/or mobile service. MD 5 also described patients 
as a future end user of PPA (along with the care community): 
“If you can use the PPA to have more patient input into it, right, so that they can actually 
help provide some of that data, then I think PPA could definitely apply to integrative medicine. 
But if you're relying on an external source to kind of plug [data] in based on what they think the 
patient has said or what [the system] thinks should happen, then…you lose that integrative aspect.”  
MD2 believed patient use of PPA could impact the referral process: 
“Maybe the patient can list attributes that they would look for in their providers…we could 
have a list of the questions to ask the patient what [they are] looking for; if we could refer you to 
a provider, geographic location, just a few things to see what would make them more comfortable. 
And we would help them to follow up and actually go to the visit or go to the provider.” 
Beyond the referral, future state PPA would also need to support the specialist protocols based on 
industry guidelines (which are constantly shifting). MD3 expected PPA outputs to mirror the 
guidelines of the National Surgical Quality Improvement Program and be updated periodically.  
Providers expected the functionality to drill down into the details to understand why the 
factors led to a specific recommendation. Instead of static screens, IM providers required the ability 
to examine information with various levels of granularity (e.g., hovering over a clinical risk factor 
or recommendation should provide additional details). Clicking on the name of a member of the 
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care community should surface details about their location, medical specialty, and any diagnoses 
and charts generated while the patient was in their care. 
The ability to review a comprehensive list of allopathic and CAM modalities and 
accept/reject options was identified as valuable, missing functionality. PPA should supplement the 
list of medication, treatment, and intervention options with links to educational content that allows 
practitioners to research and grow in their understanding of IM. MD2 wanted future systems to 
not only monitor holistic factors but also provide alerts when the dynamic pain contract was broken 
by the patient. 
In addition to key areas of innovation and aspirational functionality, providers described 
the importance of shifting the UE to support “eye contact” with patients. MD3 mentioned the 
inherent value of interpersonal connection in the patient-provider relationship: 
“You cannot lose the art of human interaction. If that's the case, you might as well just sit 
me in front of a screen and ask me a couple of questions and now I'll just talk to the screen and the 
screen [will] record it. Then you don't need to see the physician - you know what I mean - if we're 
not going to interact with the patient.”  
Participants balked at the idea of transcribing data into yet another SaaS platform. Future state 
PPA systems should support dictation and other features to remove the administrative burden 
where possible, allowing providers to be more present during patient visits.  
Finally, bias was described as the most critical pitfall that future PPA should mitigate. 
Systems should support de-selection of a clinical or socioeconomic factor the provider does not 
think should be included in the algorithms calculating risk. Certain content should be blinded to 
reduce the introduction of unnecessary data. While considered in the PPA algorithm, certain data 
may not be appropriate to show to providers seeking to give individualized care. 
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VI DISCUSSION AND CONTRIBUTIONS 
The phenomenological approach provides an in-depth look into the experience of the IM 
community of care for patients suffering from chronic pain. Reactions to three PPA screenshots 
(showing real-world data) allow for extrapolation of how PPA tools can be transformed to meet 
the unique needs of this medical community. Readdressing the research question, yes, PPA can 
support and innovate IM once significant changes are made to serve the unique needs of patients, 
providers, and the extensive community of care. 
VI.1 Comparison of Empirical Findings to the Literature  
The qualitative data confirms the value of IM as an alternative to allopathic medicine. (Oberg 
et al., 2015).  This section will address the three, secondary research questions with comparisons 
to learnings from the literature review.  
1) How does this group of professionals describe the tasks they consistently perform (e.g., the 
steps in evidence-based MDM? 
Moving beyond a static list of tasks, the phenomenological approach illuminates the 
gradual nature of MDM and the deeper relationship between patient and provider found in the 
literature (Amy Neil MS, 2019; Coulter, Snider, & Neil, 2019). Study participants adamantly 
describe IM as the only path forward for meeting the growing need for individualized care and 
improving the health of U.S. citizens. 
Results include a detailed review of the technology, including PPA Perception by Screenshot, 
Scenarios Best Supported by PPA, and Current Limitations of PPA.  
2) How does this population perceive the PPA technology currently being used in U.S. hospitals 
to predict patient outcomes and provide recommendations to providers?  
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Providers confirm the literature’s view that medical practitioners experience algorithm 
aversion and tend to reject the use of AI for critical MDM (Dietvorst, Simmons, & Massey, 2018). 
Thus, study participants recognize nearly double the PPA limitations compared to scenarios within 
which the technology supports healthcare. Practitioners also paint a consistent picture of the 
complexity of treating HICP and chronic pain, conditions that may have multiple underlying 
causes and no ultimate “cure” in some cases (Schneiderhan, Clauw, & Schwenk, 2017) (Lin et al., 
2017). The lack of peer-reviewed articles about algorithms that take into account multiple systems 
or subjective factors further explains providers’ negative perceptions of PPA. Algorithms for 
chronic pain that tend to focus on one scale or operate physiological system-by-system may lack 
the complexity to make accurate recommendations (Mueller-Peltzer et al., 2020). The technology 
simply hasn’t evolved to meet IM needs. 
Study participants’ values, attitudes, and beliefs were skewed, with the unanimous prediction 
that future convergence between IM and PPA is highly likely.  
3) How can an understanding of current IM practice be used to identify the potential usefulness 
of PPA and high-level future requirements? 
Participants need functionality across the entire spectrum of technology sophistication 
found in the literature: descriptive, predictive, prescriptive, and autonomous analytics (Oesterreich 
et al., 2020). In addition to the eight use cases for PPA in Healthcare described in the literature 
(Oesterreich et al., 2020), participants expect the future state to also support the following: Engage 
Care Community, Manage Ongoing Education and the expansion of the health monitoring use 
case to include tracking subjective factors, diet, behaviors, and lifestyle changes. And all providers 
stress the need for future state PPA to present data in an ethical manner that does not introduce 
bias to providers or negatively influence the care offered to patients (Noble, 2018). 
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VI.2 Essence of IM  
I have 20 years of professional experience in business development, management 
consulting, and program/project management in the Healthcare and Life Science space, including 
work with the largest Biopharmaceutical companies, small technology start-ups, insurance payers, 
and hospitals. I also studied the clinical pathways of gastrointestinal, cardiovascular, respiratory, 
and mental health drugs. My understanding of the nature of holistic medicine pales in comparison 
to my experience working in spaces that embrace allopathic medicine, mechanism, and 
pharmaceuticals as the first response to managing patient symptoms.  
Collective experiences as a practitioner create biases. I expect end users to adopt 
technology and/or for the proposed technology to fit the business and technical needs of the 
audience. It is surprising when participants’ responses move beyond a yes-or-no response on the 
acceptance of functionality; and instead include a visceral response as to why they fear future 
convergence. PPA fundamentally does not work for the way they practice.  
Finally, my lived experiences as a Black man in the U.S. create additional sensitivity 
toward certain topics. I have studied our Public Health system and the disparities that negatively 
impact underrepresented groups. This may affect how I receive anecdotal data about provider bias, 
access to healthcare, and the socio-economic determinants to health. Within this human context, I 
used methodology exercises like memoing and systematic coding of providers’ stories to confront 
and reduce my personal bias. Then, I performed horizontalization and used phenomenological 
storyboarding to draw out the providers’ true voice and identify the essence of IM: 
Integrative medicine is medical practice that seeks to place the control of health in the 
hands of the patient. The patient-provider journey starts with acknowledgement of the end goal: 
heal the whole person using the innate power of the mind, body, and soul. Providers use a 
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compassionate approach to affirm the patient’s humanness instead of viewing them as broken or 
diseased. Significant time investment is made to build a trusting relationship; understand the 
patient’s daily life and expected outcomes; and perform root cause analysis to identify source(s) 
of the presenting condition(s). Providers consider a comprehensive catalogue of conventional and 
CAM modalities while collaborating across a diverse community of care (e.g., physicians, 
naturopaths, nurses, psychiatrists, pharmacists, social workers, and many others). Patients are 
encouraged to have bi-directional communication in which they learn about different treatments 
and discuss their comfort level with each option. This evidence-based practice tracks objective and 
subjective clinical measures over time along with gradual lifestyle, behavioral, and dietary 
changes. Finally, the IM provider practices humility; openly expressing learnings from the 
approaches that failed and succeeded; and improving upon the dynamic care plan until the patient 
achieves sustained wellness. 
VI.3 Future-Focused Task-Technology Fit and Impact on Algorithm Aversion 
FFTTF is a new theoretical model to identify the potential fit between tasks performed 
currently and emerging technology.  
Figure 7: Future-Focused Task-Technology Fit Model 
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The figure above adapts Goodhue’s 2000 model to include future characteristics, fit, and 
performance (Goodhue et al., 2000). The FFFTF model includes the following elements: 
Table 11: Elements of the Future-Focused Task-Technology Fit Model 
FFTTF ELEMENT DESCRIPTION 
CURRENT CHARACTERISTICS 
Task Characteristics ▪ Textural and structural description of tasks performed 
▪ Same as Goodhue 1995, 2000 description 
Technology 
Characteristics 
▪ Description of technology capability/functionality 
▪ Same as Goodhue 1995, 2000 description 
Group Characteristics  ▪ Nuanced description of what a group does and how they do it 
▪ Essence identified using a phenomenological approach 
FUTURE CHARACTERISTICS 
Task Characteristics ▪ Future tasks that a group is expected to perform  
▪ Expected process transformation caused by future conditions 
Technology 
Characteristics 
▪ Ideal future state technology identified by end users 
▪ Expected updates to UE, capability, functionality 
FUTURE FIT 
FFTTF ▪ Ability for emerging technology to support task characteristics 




▪ Expected output of a group’s adoption of emerging technology 
▪ Impact of technology on an individual’s ability to execute work 
 
The current task (IM MDM) and technology characteristics (PPA) are the same elements 
described in the original Goodhue model (Goodhue, Klein, & March, 2000). Group characteristics 
(essence) is the nature of medical practice identified using the phenomenological approach that 
should be consistent across IM providers. Essence, the innate nature of how IM provider’s care for 
patients, is not expected to change over time. Future task characteristics include any additional or 
steps or process changes a group is expected to perform in the future. For IM providers the core 
set of tasks would not likely change dramatically. However, there may be nuanced changes to their 
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workflow as future tasks are impacted by new technology, regulations, and/or business practices. 
This expected shift between current and future task characteristics is represented by the dotted 
arrow. 
Future technology characteristics (capabilities and functionality) are elicited from the 
qualitative interviews: 
▪ Capability-ability of the technology to maximize positive healthcare outcomes 
▪ Functionality-ability of the technology to execute operations, tasks, functions 
This wish list represents the ideal future state to support identified tasks, to overcome the negative 
perceptions of the technology and maximize the scenarios in which it would be best suited. The 
dotted arrow between current and future technology characteristics represents the multiple 
pathways to change: incremental development over time versus innovation/industry disruption.  
Innovation and design thinking requires a willingness to transform the current ways of 
working, developing technology with the future in mind, while supporting the innate values, 
attitudes, and beliefs of IM providers. FFTTF is the measurement of how well an emerging 
technology meets the task characteristics of a group. Technology characteristics act as a moderator 
for the impact task characteristics and group characteristics have on fit (represented by solid 
arrows). High FFTTF would occur once the technology is designed to provide the expected 
capabilities/functionality and meet the innate needs of a group of end users (e.g., is a fit for their 
essence). 
The final element is group or individual performance. Similar to the Goodhue model, 
FFTTF predicts organizations will operate with greater effectiveness and efficiency when 
emerging technology supports task characteristics and group characteristics. This relationship is 
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represented by a solid arrow. As FFTTF increases, so should user adoption of technology and 
performance. 
Surprisingly, after hearing how PPA is currently being implemented in a few U.S. 
hospitals all providers believe convergence with IM in the primary care setting is inevitable. This 
belief occurs regardless of their experience with these tools or personal perception about the 
technology. However, the data suggests that even in a future where PPA is designed to meet the 
needs of IM, the technology will not be easily adopted. IM providers list several factors that 
increase their algorithm aversion or likelihood of not adopting PPA: 
▪ Low TTF to IM practice 
▪ PPA’s black box nature (e.g., no explanation about outputs) 
▪ The critical nature of their practice (e.g., life or death decisions) 
▪ The complexity of managing multiple modalities 
▪ Their specific practice is more subjective (e.g., hands-on providers, psychiatry, etc.) 
Figure 8 proposes a relationship between FFTTF and providers’ attitudes toward PPA:       
 
Figure 8: Providers’ Expected Intentions, Attitudes toward PPA versus FFTTF 
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The left side of the two-by-two diagram represents low FFTTF. In its current state, PPA 
is unfit for the way IM providers provide care. For the majority that hold negative attitudes 
towards the technology, they would reject PPA outright. Providers with more positive attitudes 
would critique the technology. Algorithm aversion would occur in both cases of low PPA fit. 
The right side of the figure represents a future state where PPA has developed to have a 
higher fit for IM. If provider attitudes remain negative, they will ignore PPA and not use it unless 
it is explicitly mandated by their employer. Algorithm aversion may still occur because providers 
don’t trust the emerging technology to meet the underlying needs of their group characteristics 
(Dietvorst, Simmons, & Massey, 2018). More simply, AA may trump FFTTF in populations that 
have very complex MDM processes and are more apt to depend on their training, expertise, and 
intuition. 
The upper right quadrant represents the stepwise nature of overcoming algorithm 
aversion. Adoption will require high TTF and a gradual path to more positive attitudes about 
PPA. Providers will first tolerate the emerging technology, then begin exploration in practice, 
and finally embrace these tools. We would expect behavioral intention to use PPA to increase if 
provider’s perceived high levels of behavioral control (Suryaningrum, 2012). Many providers 
hold concerns that adoption of another technology would introduce additional burdens and 
reduce their self-efficacy. Future state PPA must increase providers’ confidence in their 
decision-making (with access to the right information to influence behaviors) and allow them to 
feel they still control the path to wellness. 
Reapplying the Suryaningrum model, when FFTTF is high the following five steps must 
be taken to reduce algorithm aversion (Suryaningrum, 2012),: 
1. Include providers in PPA design sessions to maximize UE and increase overall EOU 
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2. Socialize system usefulness and fit to provider’s task characteristics via training 
3. Socialize accuracy of the system with transparency about any risks to patients  
4. Socialize how provider’s values and ways of working are supported by PPA  
5. Socialize efficiency gains and improved patient outcomes caused by PPA utilization  
Using the FFTTF model to direct innovation, adoption will occur faster as the future state 
technology is developed with the essence of the end user in mind. 
VI.4 Innovation Framework: Patient-Centered PPA for IM 
Healthcare IT innovators have a unique opportunity to aggressively traverse the dotted 
arrow between current and future technology characteristics in the FFTTF model. A design 
thinking approach will be required to develop software which fits the specific needs of IM 
practitioners and the multitude of IM textural and structural tasks. The innovation framework 
proposes to shift the paradigm of PPA to a patient-centered tool that manages a complex data 
ecosystem, designed for the various protocols of the extended community of care, while tracking 
the individual’s dynamic care plan over time.  
 The PPA Innovation Framework consists of three capabilities (beneficial outputs 
of the system) supported by technology functionality and an intuitive UE: Surface Healthcare 
Big Data, Center Around the Patient, and Measure the Path to Wellness. 
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Figure 9: Innovation Framework: Patient-Centered PPA for IM 
VI.4.1 Capability 1: Surface Healthcare Big Data 
PPA must manage the diverse types of information captured during the intake/assessment 
process like family history, allergies, personal history and other content found in EHR. 
Laboratory results and very large digital image files will provide the data needed for providers to 
confirm or change the diagnosis using an evidence-based approach. Information about 
concomitant medications is necessary to understand how prescribed remedies will react with any 
products the patient is currently taking.  
Portability of healthcare data from a growing number of external sources (e.g., provider 
systems, state systems, hospital records, etc.) will require interoperability across the multiple 
organizations that own the information (e.g., healthcare systems, insurance payers, healthcare 
exchanges, and others). This new way of recording, maintaining, and surfacing data will require 
strict data privacy/security rules to be compliant with current federal and state laws and 
regulations. This list includes but is not limited to: 
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▪ Health Insurance Portability and Accountability Act (HIPAA) for the protection of patient data 
and privacy 
▪ Centers for Medicare & Medicaid Services (CMS) Interoperability rule for patient access to 
data collected across platforms 
▪ State and Federal Privacy Laws to protect consumers and provide transparency into how 
healthcare organizations and companies use and/or sell personal data (e.g., California 
Consumer Privacy Act (CCPA) or the General Data Protection Regulation (GDPR) if 
managing data from European Union citizens) 
▪ U.S. Food and Drug Administration (FDA) 21 Code of Federal Regulations Part 11 for 
management of electronic records and signatures 
▪ Federal Medical Device regulations for management of Mobile Health applications like 
wearables and health tracking apps 
Interoperability requires data sources to be well defined (preferably with published and 
widely adopted data standards) and for the owners to make the aggregation of information 
readily available and easy-to-understand for the end customer-the patient. Complexity increases 
as unstructured data and data formatted inconsistently between different systems become 
necessary pieces of the IM puzzle. This will include capturing and sharing subjective data like a 
pain scale measured from a frowning face (high pain level) to a happy face (low level). 
Combining data from multiple providers (potentially from multiple states) into one record creates 
serious challenges, especially when data across systems is incongruent, follows different data 
standards, or is not easily exported and shared securely. 
If someone is admitted to the hospital, PPA would need to link the data found in the 
patient’s primary care system(s) to the EMR case. Providers in the inpatient, emergent care 
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system will need to understand what historical decisions were made by IM providers. Once 
released from the hospital, the EMR record should be surfaced to the primary care provider. A 
drop-down menu that allows the IM provider to quickly digest the history of diagnosis (across 
multiple providers) will become an integral part of the patient historical record. PPA should also 
connect with pharmacy systems to understand prescribing patterns over time and track 
compliance with medications, supplements, herbs, and other treatments. 
Wearables that collect data which could impact diagnoses and/or influence medical 
decisions must undergo federally-regulated medical device clinical trials. Devices like 
glucometers, heart monitors, and popular wearables like the FitbitTM or Apple WatchTM collect 
data that is not currently used by PPA algorithms. However, this data is extremely valuable for 
understanding the patient experience once they leave the care setting. Future state PPA must 
incorporate ubiquitous health data to truly promote measurement of the impact of lifestyle and 
behavioral changes. 
This capability also requires access to real-time data. Providers are more apt to accept 
PPA if they trust the algorithms are considering the best information available. Providers need 
visibility into the timeliness of the clinical factors, including trend data on laboratory values over 
time. PRO like the elements of a mental health screenings may require more frequent data 
collection and updating in the system. 
VI.4.2 Capability 2: Center Around the Patient 
The second capability represents a fundamental shift from how PPA systems are 
currently designed. If the true customer of healthcare is the patient, then future state systems 
must consider them as the primary end user of the technology. This significant change would 
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require the presentation of health information in simplified language based on the average 
reading level of the U.S. population (e.g., sixth grade level). Also, developers should consider 
new visualizations and/or gamification to help patients connect their individual actions, 
compliance, lifestyle changes to measurable health outcomes.  
Patients will identify their health issues, goals, and comfort level with the treatment 
options presented by providers. They will confirm the accuracy of data included in their health 
record, creating a golden record that may be shared across systems. Patients will also confirm, 
reject, and/or update their socio-economic risk factors which are currently limited to the 
opinion/perspective of the nurse/provider conducting the intake/assessment. This would allow 
providers to review pre-screen data and medical history during the assessment visit instead of 
asking a redundant list of questions and wasting time transcribing answers into a system. Patient 
ownership and validation of health records would allow providers more time to focus on care 
versus data entry. 
 When appropriate, the patient’s family, support system, and primary care provider would 
gain access to a subset of the patient’s PPA medical chart/record. Patients would also grant 
permission for their key provider or “conductor” to allow others in the community of care to 
view all or parts of the health record. The identified provider would tag a potentially large list of 
professionals: physicians, specialists, surgeons, naturopaths, pharmacists, nurses, social workers, 
technologists, and other CAM providers. This capability will require PPA to validate provider 
golden records to ensure only the correct professionals gain access.  
  This advanced accessibility functionality will require a rights and roles-based system in 
which patients (or surrogates) and providers identify who can view data. Patients would “own” 
their master record but others’ access would be revoked due to a myriad of reasons (e.g., patient 
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changes provider, outcome of a legal issue, patient becomes legal age of adulthood and 
parents/guardians can no longer view data). Protecting patient data with varying levels of 
permissions and controls would include the formidable hurdle of following the data privacy laws 
of different states and the Federal government. 
Referrals to new providers would be managed via PPA and the community would be 
alerted as individuals are added or removed from the care team. The system would flag any 
providers with past issues of malpractice, patient complaints, an/or who have their medical 
license revoked. The extended Community of Care would have bi-directional communication 
through PPA and collaborate on the patient’s dynamic care plan. They would add recommended 
CAM modalities and behavioral, diet, and lifestyle changes to the plan with explanations as to 
why they were considered.  
Future PPA technology cannot be a point solution that simply captures rows of 
information (e.g., paper forms) on screen. The UE must be practice- and patient-focused to meet 
the needs of the diverse providers in the community of care. Developers should avoid workflows 
that create unnecessary distractions or depend on unreasonable amounts of transcription, which 
effectively reduces the amount of time for true patient-provider connectedness. The PPA user 
interface should only surface the information used by that provider type or specialty. We would 
expect the information surfaced to a surgeon preparing for a highly invasive procedure to differ 
significantly from a sports medicine provider using hands-on assessments of their patient’s 
function post-surgery. 
A truly patient-centered system must address the curation of a dynamic care plan with 
shifting patient-provider expectations and medical realities. PPA will track patient acceptance or 
rejection of the elements of the care plan, creating a new set of factors to train the algorithms. 
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The resultant metric, “likelihood of patient adoption,” could help providers understand if their 
patients are apt to accept a new recommendation or modality compared to those suffering from a 
similar set of conditions.  “The patient is in control” was the central theme of IM. So, health-
focused technology must be designed to empower patients to achieve the third capability, 
Measure Path to Wellness.   
VI.4.3 Capability 3: Measure Path to Wellness 
The path to wellness starts with the IM theme that providers must understand the patient’s 
“center of gravity.” The patient’s extremely personal QOL priorities should be made visual in PPA 
with constant reminders for the care team. In order to gain patient trust and improve the probability 
of compliance, providers will suggest gradual changes, track incremental progress, and encourage 
patients to remain steadfast to meet their health goals. PPA will track subjective and objective 
measures along with PRO, to train and improve the algorithm (ML). 
PPA workflow must mirror evidence-based medical practice, with the ability to inform 
medical decisions using point-in-time data and medical trends over time. Providers will be able 
to visualize trends in clinical factors. They will receive healthcare trend alerts when conditions 
have worsened, laboratory results or digital images are abnormal, or positive progress occurred 
past certain patient- and provider-defined thresholds. For example, if a 75-year old patient were 
no longer able to play with her grandkids without experiencing back pain, her subjective diary 
entry for pain in her PPA app would be low, triggering some action for her primary care doctor, 
chiropractor or physical therapist. 
PPA will need to capture PRO, data captured from devices or mobile apps. To avoid inequity, 
more U.S. citizens will need access to technology, mobile devices, and internet connectivity to use 
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devices at home. In this innovation framework, patients would be expected to enter in their 
information and/or confirm the following types of data: 
▪ Behavior and lifestyle in a patient health questionnaire (PHQ) 
▪ Objective mental health factors like hospitalization frequency 
▪ Subjective factors like pain scores over time 
▪ History of past & current medications 
▪ Current physical symptoms and adverse events 
Capturing compliance promotes patient accountability. If a patient is struggling to follow the 
care plan or breaks his/her pain management contract, the PPA should alert the correct doctor, 
social worker, or other appropriate professional. This visibility into patient activity could prompt 
a care worker to perform a wellness check, call the patient, verify the reason for noncompliance, 
and update the care plan. Studying correlations between  provider recommendation and patient 
compliance could also provide insights into patients’ values, attitudes, and beliefs about lifestyle 
change and CAM adoption.  
Supporting a holistic approach will require systems to categorize predictions and 
recommendations into the mind, body, and spirit buckets. The new prescriptive menu will 
include the most-updated and research-supported allopathic and CAM modalities with some 
visualization of the invasiveness of each option. This advanced capability will also provide alerts 
to providers, identifying naturopathic, herbal, and botanical options and reducing the negative 
impact of prescribing the wrong pharmaceutical agents. There may be a secondary benefit that 
allopathic providers may learn more about the holistic patient with exposure to previously 
unknown treatment options and relationships forged with IM/CAM professionals.  
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PPA will get smarter by identifying correlations between evidence-based practice, 
lifestyle and behavioral changes and the resultant improvements to health, vital signs, and other 
clinical factors (see Autonomous Analytics below). Over time, we would expect the menu of 
CAM recommendations to expand and contract based on data captured in subsequent visits, on 
patient reported apps, via biometrics and other forms of real-time data. 
Options will be surfaced concerning the patient’s access to care. Social workers and case 
workers will populate a dynamic list of next steps once the patient is released from the hospital or 
receives a diagnosis from the primary care provider. This information will include transportation 
options, coupons and rebates for medications/care expenses, and other necessities for patients who 
may have different levels of mobility, financial stability, and family/support systems. 
Finally, future PPA will provide education to patients and providers about predictions, 
recommendations, and interventions. This information will be easy-to-digest for patients and their 
families in the form of short articles, expert videos, and multimedia infographics and animations. 
Education will include content for patients to better correlate lifestyle changes to positive health 
outcomes. Providers will receive links within the patient chart to peer-reviewed articles, industry 
conference presentations, disease state guidelines, and treatment protocols. As this bolus of 
information evolves, providers will be exposed to content that challenges them to learn and educate 
their patients about the most effective allopathic, IM, and CAM options. 
VI.4.4 Autonomous Analytics in Healthcare 
The FFTTF model offers researchers and practitioners a path to innovation by 
considering the wealth of opportunity between current and future technology characteristics. The 
literature defines the emerging level of Big Data sophistication as autonomous analytics 
 95 
(Oesterreich et al., 2020). Future AI deep neural networks will gradually develop the many 
layers of the IM MDM process across multiple physiological systems to identify patterns that we 
as humans simply cannot (Chin-Yee & Upshur, 2019) (Miner et al., 2014). The table below  
Table 12: Autonomous Analytics Applied to PPA Innovation Capabilities 
PPA INNOVATION APPLICATION OF AUTONOMOUS ANALYTICS 
Surface Healthcare Big Data ▪ Identify missing data sources that negatively impact the 
algorithm and revalidate system accuracy 
▪ Educate providers on the collective impact of data sources 
▪ Allow providers to build, test, and train their own models, 
incorporating data sources supporting provider-unique 
protocols 
▪ Identify issues of latency, and the impact of not having real 
time data on system accuracy 
▪ Risk factors identified by the data prompt the system to 
recommend additional laboratory tests 
Center Around the Patient ▪ Suggest subjective factors to collect from patients 
▪ Identify barriers to care based on patient parameters 
▪ Predict impact of case and social workers resources on 
patient outcomes 
▪ Identify additional providers to add expertise/medical 
specialty to the community of care 
Measure Path to Wellness ▪ Identify patient education needs and their understanding 
of CAM options, lifestyle and behavioral changes 
▪ Design a dynamic care plan with “center of gravity” or 
QOL goals 
▪ Identify the objective and subjective clinical factors to 
track based on patient population and wellness goals 
▪ Analyze the risk of making recommendation patients do 
not understand or accept and inform providers on the need 
for patient education 
▪ Recommend stabilization and placement options for 
patients presenting in a mental health crisis 
▪ Recommend less invasive or more invasive treatments 
based on risk levels set by patient and provider 
▪ Update algorithms based on provider feedback on clinical 
and socioeconomic risk factors 
▪ Update algorithms based on and patient input/feedback on 
health goals, compliance levels, and health outcomes 
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Autonomous analytics will empower the technology to learn from historical patient data 
and apply combinations of treatment, CAM modalities, and lifestyle change across different 
populations and levels of wellness. Within a certain degree of statistical significance, 
sophisticated technology will apply learning from chronic pain to lupus patients or another 
condition(Creswell & Poth, 2016). (Creswell & Poth, 2016).. Correlations between the 
combination of intermittent fasting, proper hydration and supplements to decrease inflammation 
in pain patients may be modeled against diabetic patient data, creating new, evidence-based 
treatment protocols.   
Ideally, future state systems would surface a prediction, a recommendation and a “second 
opinion.” The Healthcare IT community must move beyond “black box” PPA toward 
autonomous analytics systems that allow for dynamic algorithms (Miner et al., 2014). Imagine a 
feedback loop within which providers can accept or reject the factors used by PPA. Providers 
want to understand how removing a factor or changing a subjective score impacts system 
recommendations. If the end user changes the elements included in the algorithm using the drag-
and-drop functionality (e.g., intuitive workflow), the system should educate her or him on the 
potential impact to the patient. The new prediction, recommendation, or interventions could be 
displayed with a color code or numeric grade to denote the new level of accuracy. The future of 
second opinions may be achieved by autonomous analytics’ ability to make accurate predictions 
and recommendations within differing sets of MDM parameters and/or medical protocols. 
Autonomous analytics will incorporate a feedback loop between the diverse community 
of care/patient support system and the technology. As providers add or remove factors from the 
menu, a sophisticated system may ultimately state that no statistically significant prediction or 
recommendation can be made within the self-selected parameters. Providers would review the 
 97 
audit trail to the original algorithm to understand how changing factors impacted predictive and 
prescriptive results. Tremendous computing power will be needed to maintain this disclosure, 
analysis, and reconciliation between complex algorithms and their human symbionts.  
Finally, autonomous analytics will find patterns across a wealth of objective and 
subjective variables. Future PPA will be driven by epigenetics, trends in vitals/labs, and real-time 
biometrics. Laboratory data and patient reported adverse events will also be analyzed to identify 
combination therapies and contraindications across pharmaceuticals, botanicals, supplements, 
and herbs. Algorithms that test complex models (e.g., calculate the expected patient outcomes 
using medicine, treatment, and intervention) could be used to run virtual clinical trials. This 
approach will allow researchers to conduct patient- and provider-less clinical trials that put no 
humans at additional risk. These evidence-based CAM trials will scientifically predict the 
outcomes of less invasive care, behavior, and lifestyle change on patients seeking wellness or 
those suffering from serious conditions. 
VI.4.5 Ethical Algorithms 
The group characteristics of IM providers include a focus on ethical behavior. 
Participants have concerns over the potential for PPA to negatively influence medical practice. 
They identified ways in which presentation of data (particularly race, socioeconomic risk factors, 
and insurance status/payer) may bias a provider’s decision making (Noble, 2018). The following 
functionality should reduce provider bias:  
▪ PPA should blind factors that cause providers to treat patients unequally 
▪ PPA should recommend CAM options with descriptions of the risk of change 
▪ PPA should prioritize interventions by level of importance and relative risk of not starting 
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All CAM options should be surfaced to the provider and patient regardless of assumptions on the 
healthcare customer’s ability to afford them. Regardless of the outputs of PPA tools, no one 
should be denied access to care or discriminated against in any other way. For example, if an 
algorithm determines a patient has a propensity for a disease, she or he shouldn’t be denied 
insurance coverage or be employment opportunities. 
Ethical algorithms allow providers to drill in and out of the data. A higher level of visibility 
into how PPA operates would increase trust in the system functionality and accuracy, reducing 
algorithm aversion. But more importantly, moving away from “black box” PPA lets providers 
better understand how factors were used to inform a prediction and why certain recommendations 
were made (Miner et al., 2014). The ability to uncover this level of granularity is considered ethical 
because it promotes better-informed decisions. 
Finally, PPA or any other future technology may never replace the intrinsic value of 
physical presentation. More human intervention is needed for critical or emergent patients (e.g., 
mental health, depression, suicide risk, etc.). So, even if future PPA is a fit for IM MDM task 
characteristics, adoption won’t occur if the system takes time away from busy healthcare workers 
and/or could introduce risk to complex patients. The value of future tools will be in their ability to 
enhance the patient-provider interaction and provide practice-specific information just-in-time. 
VI.5 Contributions 
FFTTF is a reconceptualization of the heavily published TTF theory (Goodhue, 1995).  
While TTF is traditionally applied to technology already in use, FFTTF provides directional 
understanding of whether emerging technology will meet the needs of a well-defined population 
of end users in the future. As FFTTF increases over time (e.g., software development delivers 
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better technology with more fit), it is proposed that Algorithm Aversion (negative attitudes 
toward adoption of PPA) will gradually decrease.  
FFTFF allows researchers, technologists, and strategy consultants to perform design thinking 
within specific industry constructs (e.g., a company, customer type, or end user is the unit of 
analysis). This contribution to theory provides a new framework within which to: 
▪ Consider the impact of innovation on a unique groups of end users 
▪ Develop technology to fit the needs of a group of end users 
▪ Increase emerging technology adoption rates 
▪ Down-select technology options for the best fit to solve a group or organization’s needs 
▪ Transform healthcare and business processes with innovative technology 
The FFTFF model provides insights needed to create business strategy, software development 
roadmaps, and innovate based on real-world needs or group characteristics. 
Using PPA screenshots to identify FFTTF represents a secondary methodological 
contribution. This qualitative approach uses interviews to develop a high-level understanding of 
tasks performed. Researchers read back each high-level task (identified during the interview) to 
the participant and identify how the emerging technology (shown visually as screenshots, a 
recorded demonstration, or other visual representation) supports or does not support each task. 
Then, individual perceptions of the technology are identified, including proposed areas of 
modification, likelihood of adoption, and thoughts on future convergence with the phenomenon 
being investigated. This process can be easily reused by researchers hoping to understand how 
groups sharing a phenomenon view emerging technology (see Figure 9 in the Appendix).  
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This research makes a new contribution to phenomenological research methods that use 
interviews to identify unique group characteristics (Creswell & Poth, 2016). The following seven 
steps visualize relationships between the elements of a phenomenon to develop a complete story: 
1. Identify textural and structural tasks (what and how) via interviews; 
2. Code interviews to identify what is unique about the phenomenon (horizontalization); 
3. Use phenomenological storyboarding to organize the participants’ essence statements 
(descriptions of the nature of tasks) in a logical and temporal order;  
4. Overlap related essence statements that often occur together or in an iterative fashion; 
5. Identify subthemes for a group of connected essence statements; 
6. State personal biases that may impact the story and methods used to reduce them; and 
7. Present the composite of themes as a clear essence statement. 
Theoretical saturation must occur before the researcher can safely horizontalize the qualitative 
data. There is a risk that the essence statement will be incomplete if phenomenological 
storyboarding is started too early without a strong understanding of current task and group 
characteristics.      
The research makes contributions to the problem setting, exploration of the potential 
application of PPA to IM practice. The comparison of tasks to technology characteristics creates 
a unique offering to the literature which currently lacks qualitative descriptions of provider 
perspectives of emerging AI task characteristics technology. The detailed empirical description 
of IM MDM task characteristics makes it easier to see PPA is not currently a fit for these 
professionals. The rich, contextual description of “essence” provides legitimacy to IM which is 
gaining momentum in U.S.  Socialization of IM’s value may help patients and providers 
overcome misconceptions about IM, NM and the effectiveness of CAM modalities.  
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Every study participant felt PPA would eventually be applied to IM whether they supported 
the technology or not. IM providers’ insights on PPA’s overall fit are a unique contribution to the 
area of concern (answering the research question):  
▪ Providers’ perceptions of current PPA tools (positive, neutral, and negative) 
▪ Healthcare scenarios best suited for PPA  
▪ Providers’ perceptions of future convergence of IM and PPA 
▪ Comprehensive list of suggested modifications to PPA 
▪ Factors impacting likelihood of PPA adoption 
▪ Innovation framework to direct development of future state PPA  
▪ Future state use cases for autonomous analytics in healthcare 
Understanding new avenues for applying evidence-based medicine (e.g., predicting and 
measuring patient outcomes) is relevant to practitioners and Healthcare/Life Sciences technology 
vendors. Developing emerging technology based on research of group characteristics may lead to 
faster adoption rates than we have seen with other innovations like electronic data capture in 
clinical trials, EHR/EMR in inpatient and outpatient care, and even digital imaging.  
VI.6 Limitations  
Rich study results required the proper sampling of interviewees with IM licensure (e.g., 
doctors, nurses, etc.) and experience with chronic pain patients. This research left out massage 
therapists, traditional Chinese medicine (TCM) and other CAM providers who may have shifted 
the group characteristics. It is also possible that other supporting cast members like social 
workers and case workers would have identified a separate set of tasks not captured in the 
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results. Most importantly, the research did not include the voice of patients to identify their needs 
and confirm the Innovation Framework.  
There were limitations to the application of phenomenological research to the medical 
community. Due to doctors’ schedules, the process of finding time slots and confirming the 
virtual sessions was difficult. After the first two interviews, both sessions were combined into 
one longer call. This strategy increased the likelihood of completing the full set of questions for 
these busy professionals. However, it reduced the time available to review the list of tasks before 
asking the second set of questions to ascertain FFTTF.  
At the time of this study, PPA for IM did not exist. All participants required education on 
the technology. The use of static screenshots was selected to focus interviews on a concise set of 
system functionality. But this process of digesting static screenshots made it more difficult for 
some participants to grasp PPA. Several interviewees required additional explanation, so the 
description of the technology was not uniform across the cohort. Others asked questions that 
were not central to the study; went above and beyond my knowledge of how the algorithms were 
designed; or could only be answered via a demonstration using a live user interface. Genericized 
answers to these technical questions may have reduced the robustness of participants’ answers.  
Finally, there may have been different results if another disease state was used as the 
research case. While complex and widespread, chronic pain has very many causes and a 
multitude of treatment protocols based on the type of treating practitioner. It is possible that 
another chronic disease like diabetes or hypertension would have led practitioners to show less 
algorithm aversion and consider PPA a better fit for treating those patient populations. 
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VI.7 Future Research 
The success of using a phenomenological approach to explore FFTTF opens up several 
new areas of research. This theory can be applied to many disciplines or industries to identify 
areas of innovation. As the theory evolves, futurists may move past the current task-future 
technology paradigm to future task-future technology. These studies would be designed to 
explore fit between seemingly incongruent, emerging technologies and the ideal future state of 
IM practice to challenge the status quo of medical practice. The technology would be introduced 
to participants visually and they would provide a deeper dive into how adoption could totally 
shift future tasks characteristics (e.g., break and rebuild current processes to define areas of 
innovation).  
There is an opportunity to further dissect phenomenological storyboarding to validate if 
this technique produces generalizable or reproducible results. Methodology research could 
include testing the best ways to codify tasks into themes and then perform horizontalization. 
Validated results would create methods for researchers and consultants to quickly identify the 
essence of groups and better understand their unique technological needs. 
Within IM, there is an opportunity to better understand how providers collaborate and 
communicate, using a group of practitioners as a case (or several groups in a multi-case study). 
Qualitative research focused on the voice of the provider could identify the specific tasks, 
perspectives, and needs of each subgroup/medical specialty. This could identify treatment 
protocols across different areas of holistic medicine which would be used to design new PPA 
algorithms and shape the UE of receiving and managing recommendations and interventions.  
Similar studies (both qualitative and quantitative) could be designed with the patient as 
the unit of analysis. There is an opportunity to research gamification of holistic medicine that 
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focuses on the impact incentivization has on provider and patient adoption of CAM modalities. 
This avenue would identify new ways to educate people on the benefits of holistic medicine and 
help them associate diet, behavior, and lifestyle changes with better health outcomes. 
Within PPA, there is a need to better understand how to overcome algorithm aversion and 
experiment with different ways of presenting risk scores, recommendations, and interventions 
(e.g., alternatives to the “black box”). These studies could also focus on the role of data 
presentation on provider MDM and experiment with the concept of “blinding” to reduce provider 
bias and algorithm aversion. Technology modeling could be used to further understand how PPA 
will support: 
▪ Measurement and analysis of subjective and nonverbal health factors 
▪ Dynamic care plans with input from the extended care community 
▪ PRO and real-time data collection from wearable devices  
▪ Interoperability of a larger set of data sources, data security, and data privacy 
▪ The shift to autonomous analytics (e.g., application of health outcomes to new protocols)  
Finally, policy studies are needed to highlight the ethical considerations around the 
development of PPA. There will be a need to revisit federal and state data capture, data 
management, reporting, and patient privacy regulations to address the new challenges created by 
this field of emerging technology. 
VI.8 Conclusion 
This engaged scholarship used a phenomenological approach to identify the essence of 
how IM practitioners make decisions to improve patient outcomes. Chronic pain was selected as 
the case due to its prevalence in the U.S., complexity, and likelihood of being treated using IM. 
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Phenomenological storyboarding identified and visualized themes in IM tasks, aiding creation of 
an essence statement. This group of professionals described their practice as empowering for 
patients and unique from conventional, allopathic medicine. 
Using the FFTTF theory, the research showed that PPA must go through a significant 
overhaul to meet current IM task characteristics and deliver the desired future state capabilities. 
Based on feedback from providers, PPA was fitting for emergent care where information could 
be missed by doctors and conditions that had well-understood and formulaic treatment protocols. 
Doctors benefit from technology that aggregates and exposes historical information, providing a 
clear patient snapshot. However, PPA was designed for allopathic systems that treat sickness 
versus tracking patients toward wellness, so it had low fit for IM decision making.  
In the ideal future, PPA will be designed with a better understanding of the IM task and 
group characteristics. It should be designed to take a patient-centric approach and support the 
unique way providers practice medicine. PPA must not introduce administrative and 
transcription burden and should instead put time back in the hands of busy professionals, 
enhancing the patient-provider experience. Individualized care and holistic medicine focused on 
the mind, body, and spirit will require technology that captures and surfaces information from a 
complex data ecosystem, allows for communication and collaboration across the community of 





Appendix A: Research Design Summary (adapted from Mathiassen, 2017) 
RESEARCH 
COMPONENT 
     DETAILS 
Title Phenomenological assessment of Integrative Medicine decision-making 
and the utility of Predictive and Prescriptive Analytics tools  
Area of 
Concern 
▪ Exploration of the essence of integrative medicine (IM) to understand if 
predictive and prescriptive analytics (PPA) may or may not be a fit for 
this type of medical practice 
Problem 
Setting 
▪ More U.S. patients are seeking integrative medicine to complement or as 
an alternative to allopathic or “Western” medicine 
▪ PPA technology is currently used in U.S. hospitals to predict/measure 
patient outcomes and recommend treatment, interventions, medications, 
etc. 
▪ PPA technology is not currently designed for IM or the primary care 
setting 
▪ There is a lack of qualitative research describing provider perspectives on 
application of emerging technology (AI/ML/PPA) on decision-making 
Conceptual 
Framing 
▪ FA: Task-Technology Fit (TTF) (Goodhue and Thompson, 1995) 
▪ Understand the tasks characteristics (activities the user must perform) and 
technology characteristics (capabilities of the future state PPA tool).  
▪ Expectation that subset of study participants will demonstrate algorithm 
aversion, an unwillingness to defer their expertise/intuition to the 
recommendations of artificial intelligence (PPA). This is exacerbated 
when providers can’t intervene with the technology or modify the results. 
Method ▪ Qualitative, interpretivist research that uses a Phenomenological 
approach (Creswell, 2013) to distill the common “essence” of IM 
practitioners, identifying the WHAT and the HOW of the patient-
physician relationship. 
▪ Performed semi-structured interviews virtually. The first half identified 
IM tasks. In the second half, participants were shown screenshots of a 
PPA tool used in U.S. hospitals to understand providers’ perception of 
the technology and TTF (at a conceptual level). 




▪ How can predictive and prescriptive analytics tools (PPA) 
support/innovate integrative medicine decision-making processes and 
improve outcomes for patient populations suffering from chronic pain? 
Contributions CP 
▪ Detailed empirical description of the “essence” of integrative medicine 




▪ Insights on the task characteristics of integrative medicine 
▪ Providers’ perceptions of current PPA tools (positive, neutral, and 
negative) 
▪ Healthcare scenarios best suited for PPA  
▪ Providers’ perceptions of future convergence of IM and PPA 
▪ Comprehensive list of proposed modifications to PPA 
▪ Factors impacting likelihood of PPA adoption 
▪ Innovation framework to direct development of future state PPA  
▪ Future state use cases for autonomous analytics in healthcare 
CT 
▪ Future-Focused Task-Technology Fit model to predict fit of emerging 
technology to current task performed by unique individuals/groups 
▪ Theoretical link between FFTTF and Algorithm Aversion 
CM 
▪ Sharing visualization of technology screenshots with medical 
professionals to gain perceptions of an emerging technology 
▪ Phenomenological storyboarding process to identify essence 
 
Appendix B: Analysis of Study Validity 
Study # Research 
Approach 
Empirical Basis Analysis 
Method 
Overall Validity 
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measurement 
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Appendix C: Key Findings from Literature Review 
 
FINDING 1 FINDING 2 FINDING 3 TRANSLATION 
Study 1 “The increasing 
availability of 
healthcare data and 
rapid development 
of big data analytic 
methods has opened 
new avenues for use 
of AI and ML based 
technology in 
medical practice” 






the point of care is 
limited, and their 
regulatory and 
commercialization 
pathway is not 
clear. ” 





few have been 
implemented 
widely at the 
point of care” 
Further research 




logistics, and data 
exchange and 
privacy  
Study 2 “We find that deep 
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in the field, but 




is very large, with 
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patients are highly 







but given how 
Unique 
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described in the 
research. 
However, 




have been made on 
the prior state of the 
art.” 
heterogeneous 
and may present 
with very 
different signs and 
symptoms for the 
same disease” 
rapidly the field 
is evolving, we 
are confident 







complex and not 
well understood 
Study 3 “We are still some 
ways from 
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soon be replaced 
by AI are indeed 
overstated” 
“The growth of 
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needed to avoid 
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the clinical diagnosis 
based on modern 

















lung diseases in 
integrative 
medicine” 






Study 5 “Technological 
advancements 
permit the collection 












the benefit of the 

















may create bias 
and/or misuse of 
AI tools 
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Study 6 Chronic pain 
patients present with 
complex list of 
symptoms and are 
willing to try 
multiple modalities 
“Patients who 
have chronic pain 
and who present 





















care provided in 
a medical 
home.” 
IM has value for 
complex patients 





research is needed, 
not enough is 
known about how 
emerging tech will 






















of tech  
There is room for 
exploration. 
Research on the 
use of PPA to 




Appendix D: Medical Practice, Description and Modalities 
MEDICAL PRACTICE DESCRIPTION MODALITIES 
Allopathic Medicine “Western” medicine, disease-
based, prescribe drugs, seek a 
specialist, deductive, not holistic 





Complimentary when used in 
addition to Allopathic; Alternative 
when used instead of Allopathic; 
CAM, intuitive may be applied 
holistically 
Behavioral changes, Massage 
therapy, sound, herbalism, 
aromatherapy, yoga, 
chiropractic, acupuncture, 
massage therapy, dietary 
supplements, homeopathic 
and naturopathic medicine 
Naturopathic Medicine Ethnic and “traditional” healing, 
natural, wellness-based, many 
global flavors, holistic 
Clinical nutrition, smoking 
cessation, herbalism, colon 
therapy, Ayurvedic medicine 
Integrative Medicine Focus on patient-physician 
relationship, health and wellness, 
behaviors, holistic care plan 
Primary Care, Specialty Care, 
Surgery, Pharmacy, CAM & 
Naturopathic modalities  
Note. This is not an exhaustive list. These categorizations propose the differences between 
medical practice based on the level of holistic approach and philosophical views on the nature of 
health/wellness and root cause of disease/unwellness. 
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Appendix E: ICD-11 Designation for Primary and Secondary Chronic Pain 
Chronic primary pain is characterized by disability or emotional distress and not better 
accounted for by another diagnosis of chronic pain. Here, you will find chronic widespread pain, 
chronic musculoskeletal pain previously termed “non-specific” as well as the primary headaches 
and conditions such as chronic pelvic pain and irritable bowel syndrome. They are recognized as 
a group of chronic pain syndromes for the first time in ICD-11. Chronic secondary pain is 
organized into the following six categories: 
1. Chronic cancer-related pain is chronic pain that is due to cancer or its treatment, such 
as chemotherapy. It will be represented in the ICD for the first time.  
2. Chronic postsurgical or post-traumatic pain is chronic pain that develops or increases 
in intensity after a tissue trauma (surgical or accidental) and persists beyond three months. It is 
also part of the ICD for the first time.  
3. Chronic neuropathic pain is chronic pain caused by a lesion or disease of the 
somatosensory nervous system. Peripheral and central neuropathic pain are classified here. These 
diagnoses are also newly represented in the ICD. 
4. Chronic secondary headache or orofacial pain contains the chronic forms of 
symptomatic headaches (those termed primary headaches in the ICHD-3 are part of chronic 
primary pain) and follows closely the ICHD-3 classification. Chronic secondary orofacial pain, 
such as chronic dental pain, supplements this section. 
5. Chronic secondary visceral pain is chronic pain secondary to an underlying condition 
originating from internal organs of the head or neck region or of the thoracic, abdominal, or 
pelvic regions. It can be caused by persistent inflammation, vascular mechanisms or mechanical 
factors. 
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6. Chronic secondary musculoskeletal pain is chronic pain in bones, joint and tendons 
arising from an underlying disease classified elsewhere. It can be due to persistent inflammation, 
associated with structural changes or caused by altered biomechanical function due to diseases of 
the nervous system. (Barke, January 17, 2019) 
Appendix F: Recruitment E-mail Template 
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Appendix G: Informed Consent Form 
Title: Phenomenological assessment of Integrative Medicine Decision-Making and the 
Utility of Predictive and Prescriptive Analytics Tools 
Principal Investigator: Dr. Carol Saunders 
Co-Investigator: Dr. Lars Mathiassen  
Student Principal Investigator: Osie Gaines, III 
 
Procedures 
You are being asked to take part in a research study. This research is focused on the use 
of predictive and prescriptive analytics (PPA) technology to predict patient outcomes and 
provide recommendations for treatments or interventions. The research team is interviewing U.S. 
integrative medicine providers that are currently treating patients suffering from chronic pain. 
If you decide to take part, you will be asked to participate in two virtual interviews 
focused on the following: 
▪ Session 1: Understanding the medical decision-making process when treating patients 
holistically 
o You will answer questions about your process with chronic pain patients 
o Estimated duration is 30 minutes-1 hour 
▪ Session 2: Getting your feedback on PPA technology (duration is 30 minutes-1 hour) 
o You will view screenshots from PPA technology currently used in hospitals 
o You will answer questions about how PPA may or may not fit your ways of working 
o Estimated duration is 30 minutes-1 hour 
If it is more convenient for you, both interviews can be combined into one session 
(estimated to last 1-2 hours). Based on your response, the research team will schedule the 
interview(s) and send WebEx virtual meeting invitations to your e-mail address. 
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The interviewer will be located in Atlanta, GA (Eastern time zone). Your interview 
responses will be recorded via the WebEx software and using a separate audio recorder. These 
files will be maintained in a secure location. No one outside of the research team will have 
access to these audio files. Information that can identify you individually will not be released to 
anyone outside the study. Once the research is finalized, these recordings will be permanently 
deleted. 
Compensation  
You will receive the following compensation for participating in this study: 
▪ $40 USD for participating in the first session; and 
▪ $60 USD for participating in the second session 
Compensation will be provided in the form of gift cards or donations to the Healthcare-
focused non-profit organization of your choice. Compensation will be paid within one week of 
interview completion. 
Voluntary Participation and Withdrawal  
The Georgia State University Institutional Review Board has reviewed my request to 
conduct this project (IRB number 21115).  Your participation in this study is voluntary. You do 
not have to be in this study. You may skip questions during the course of the interview or stop 
participating at any time. For example, if you are only able to complete the first interview, you 
will not be coerced to complete the second interview.   
Contact Information  
Carol Saunders: csaunders@gsu.edu 
Osie Gaines: ogaines2@student.gsu.edu  
 
Consent  
If you are willing to volunteer for this research, please give your verbal consent to the 
researcher.  
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Appendix H: Semi-Structured Interview Script 
 











Background 1. Please state your name, current role, licensure, and 
years of professional experience. 
2. Is your medical license recognized by the state in 
which you practice? What’s the impact on your 
patients? 
3. How and where were you trained in medicine?  
4. At a high level, please describe your methods when 
treating a patient with chronic pain. 
5. At a high level, please describe how you would identify 
the risk level for patients. 
6. What are some difficulties/areas of complexity for 




Integrative medicine focuses on health and healing and 
emphasizes the centrality of the patient-physician 
relationship. In addition to providing the best conventional 
care, integrative medicine focuses on preventive 
maintenance of health, wellness, behaviors, and a holistic 
care plan.  
1. How would you describe the integrative MDM 
process? 
2. What is unique about integrative medicine that leads to 
successful patient outcomes? 
3. How do you apply a holistic approach to a patient with 
chronic pain? 
4. Can you share an example when your 
intuition/expertise made you reject the standard of care 
or prescribe something other than the gold standard 
medicine for a patient? 
5. Please describe the tools/technology you currently use 
to measure/predict chronic pain patient outcomes. 
6. Please describe the tools/technology you currently use 














▪ Show the participant screenshots of an AI tool that uses 
PPA to aid medical decision making 
▪ Show examples of a chronic pain patient 
▪ Describe the data source used by the PPA, the 
algorithm used, and the outputs 
1. What is the extent of your experience with PPA tools?  
2. What do you like most/least about this tool (overall 
perception, user experience, presentation of 
information)? 
3. How could these systems be modified to better serve 
you? What additional inputs/outputs are needed? 
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4. What would cause you to doubt the outputs of these 
types of systems when treating patients holistically?   
5. Can you share a scenario in which your 
intuition/expertise would make you reject the outputs 
of PPA?  
6. Which patient types/MDM scenarios are best supported 
by these types of tools? Which are least suited? Why? 
Ideal Future State  Revisit the elements of the predictive analytics tool and 
shift to future state questions: 
1. Should there be a convergence between PPA and 
integrative medicine? Why or why not? 
2. Which types of decisions could be supported by PPA? 
Which decisions are inappropriate for PPA? 
3. What is the potential for PPA tools to replace parts of 
your MDM process? Why or why not? 
4. How will technology be used to predict and measure 
patient outcomes and provide recommendations in 10 
years?  
5. Is there anything else I haven’t asked about your MDM 












PPA Tool Experience 
Other Technology in Use 
▪ Descriptive statistics  
▪ Provider’s description of their current role and 
medical licensure (including if it was recognized by 
the state of practice) 
▪ Details about how they were trained in medical 
schools, institutions, and other ways 
▪ Years of experience working with patients 
▪ Experience using predicative and/or prescriptive 
tools 
▪ Additional technology/tools used to manage work, 
predict patient risk/outcome, and/or recommend 
actions 
Patient Stories ▪ Includes stories of an anonymized patient’s 
symptoms, their personal journey, and outcomes.  
▪ It also includes any descriptions of patient’s 
perspective of the provider relationship and care 
received.  
Impactful Quotes 
Essence of IM 
▪ Quotes in which the provider described a process or 
topic passionately and with sincerity.  
▪ It also includes descriptions of the essence of IM 
and/or nuance in the way they work with patients. 
Task Characteristics: Textural  
Perform Intake/ Assessment 
Make/ Update Diagnosis 
Create/Manage Treatment Plan 
Engage Care Community  
Perform Administration 
Manage Ongoing Education 
Other 
▪ High-level code-WHAT providers do 
▪ Steps taken to collect historical and real-time 
patient data 
▪ Steps taken to confirm, reassess, and update the 
patient diagnosis 
▪ Steps taken to create, reassess, and update the 
treatment plan and/or pain contract 
▪ Steps taken to refer a patient to another provider, 
communicate and collaborate with the community 
of care 
▪ Steps taken to perform insurance payer, state 
regulation, and other types of 
legal/financial/managerial administration 
▪ Steps taken to educate the patient or provider on 
allopathic and CAM modalities 
▪ Any additional tasks 
Task Characteristics: Structural  
Holistically 
Gradually 
Using Objective & Subjective 
Data 
Within Care Community 
▪ High-level code-HOW providers perform tasks 
(contextual) 
▪ Descriptions of mind, body, spirit approach 
▪ Descriptions of stepwise approach  
▪ Descriptions of diverse data types 
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While Empowering Patients ▪ Descriptions of how the care community 
communicates and collaborates 
▪ Descriptions of patient-focused approach 
Technology Characteristics 
Screenshot 1 (Positive, Neutral, 
Negative) 
Screenshot 2 (Positive, Neutral, 
Negative) 
Screenshot 3 (Positive, Neutral, 
Negative 
▪ High-level code 
▪ Includes modifications, additional inputs/outputs 
TTF, Ideal Future State 
Convergence (Positive, Neutral, 
Negative) 
Scenarios Best Supported by 
PPA 
PPA Modifications, Additional 
Inputs/Outputs 
▪ High-level code 
▪ Values/Attitudes/Beliefs on future convergence of 
IM and PPA 
▪ Description of the patient types, care scenarios best 
supported by PPA 
▪ Descriptions of proposed changes to make PPA a 




Appendix J: Additional Evidence from Qualitative Interviews 
Table J1: High-level Tasks Identified during IM Portion of Interviews 
INTEGRATIVE MEDICINE TASKS      
▪ Take a gradual approach      
▪ Manage ecosystem of providers 
▪ Communicate options with patients 
▪ Treat Holistically (Mind, Body, Spirit) 
▪ Take patient history 
▪ Perform physiological, neurological, & chiropractic assessment 
▪ Order and analyze imaging/x-rays 
▪ Track compliance with treatment plan 
▪ Provide immediate feedback to patients 
▪ Track stepwise recommendations and results 
▪ Record results of 1 to 3-hour assessment 
▪ Assess patient across 3 angles  
▪ Manage referral process 
▪ Collaborate with other providers 
▪ Track provider’s unique spreadsheet of key factors 
▪ Track parasympathetic factors 
▪ View ultrasound results 
▪ Track details for complex patient 
▪ View past medical history 
▪ View patient’s story over time 
▪ Track lifestyle modification 
▪ Reassess original diagnosis (including from another provider) 
▪ Analyze comorbidities 
▪ Identify “center of gravity” (objective and subjective goals) 
▪ Support multi-organ approach 
▪ Order a food panel and analyze results 
▪ Track small steps over time 
▪ Record feedback – SOAP Notes 
▪ Collaborate with rheumatologist 
▪ View advanced imaging 
▪ Conduct Functional Screening 
▪ Review Orthopedic Test Results 
▪ Record results of 1-hour first visit, history, previous surgeries 
▪ Communicate with functional medicine or naturopathic doctor 
▪ Record patient reported pain scale 
▪ Monitor daily habits 
▪ Review patient prescription history 
▪ Follow state guidelines for controlled substance management 
▪ Track patient trust level 
▪ Record treatment plan and pain contract 
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▪ Track changes to the comprehensive treatment plan 
▪ Manage referrals and flag bad providers 
▪ Collect patient history 
▪ Record results of the clinical evaluation and physical exam 
▪ Follow risk models based on specialist protocols 
▪ Refer to other providers 
▪ Track changes to behaviors and lifestyle 
▪ Record detailed history 
▪ Track lifestyle over time 
▪ Record psychosocial functions 
▪ Record notes about impact of antipsychotic meds 
▪ Educate patients about holistic options 
▪ View lab results 
▪ Identify CAM modality options 
▪ Help patients associate changes to QOL (gamification) 
▪ Share homework/research topics with patients 
▪ Identify barriers to compliance 
▪ Identify psychosocial factors impacting health 
▪ Communicate with mental health networks 
▪ Interview patient to agree upon a care plan 
▪ Request and view previous records 
▪ Manage disability application paperwork and process 
▪ Interact with state Medicare system for opioid misuse 
▪ Refer to pain specialists, case managers, social workers 
▪ Receive education on additional modalities, articles, guidelines 
▪ Record subjective pain measures 
▪ Align on a care plan 
▪ Order additional labs and view results 
▪ Document psychiatric medication treatment plan 
▪ Perform acute crisis stabilization (disposition planning) 
▪ Use talk therapy to track patient to resolution 
▪ Track lifestyle modifications 
▪ Conduct safety assessments to identify red flags 
▪ Perform screening questionnaires and record diagnosis 
▪ Request bloodwork and record results 
▪ Track concomitant medication data and physical symptoms 
▪ Collect detailed medical history 
▪ Manage treatment options 
▪ Collect controlled substance history 
▪ Record matrix of CAM modalities and outcomes over time 
▪ Mange pain medication contract and morphine dose equivalence 
▪ Keep tracking of lifestyle and diet management at the forefront 
▪ Monitor bloodwork and metabolic deficiency 
▪ Record subjective pain scale measure 
▪ Manage referrals to other providers 
▪ Take medical history 
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▪ Perform physical exam 
▪ Collect vital signs and biometrics 
▪ Involve social workers 
▪ Refer to specialists 
▪ Track behaviors and lifestyle      
▪ Track diet and gut rest (intermittent fasting) 
▪ Perform genetic testing 
▪ Perform ultrasound 
▪ Perform lab work 
▪ Research new scientific knowledge 
▪ Review patient questionnaire/Interview for history 
▪ Review X-rays/images 
▪ Identify barriers to accessing care 
▪ Introduce many modalities 
▪ Manage diet, lifestyle, and water intake 





Table J2: Task Characteristics Coded from Interviews 
TASK CHARACTERSTICS 
Accept patient input on meds they want to take 
Accept that another provider may correctly disagree with your assessment 
Accept the value & frequency of second opinions 
Actively listen as core of mental health practice 
Actively manage meds with goal to titrate down over time 
Add physical therapy when patient is ready 
Address diet and nutrient levels 
Address Factors leading to Dysfunction 
Address Hydration Without Punitive Approach 
Address Mental Health 
Address mental health first 
Address sleep to reduce anxiety 
Address Spiritual Health 
Admit to psych facility if patient poses threat to themselves or others 
Allow patients to choose provider who support other ways of practicing 
Allow several visits to build trust 
Apply Chinese Medicine Perspectives 
Apply Cognitive Behavioral Therapy 
Apply Gradual Recommendations Across Frequent Visits 
Apply Spirituality Gradually for Non-Religious Patients 
Approach Chronic Pain from 3 Angles 
Ask additional questions to identify barriers to care 
Ask additional questions to supplement the care community 
Ask critical questions to complete patient safety assessment 
Ask myriad of questions to perform root cause analysis 
Ask patient's comfort level with options 
Ask questions to identify stress, lifestyle, diet 
Ask questions to take holistic approach 
Ask questions to understand what modalities patients will consider 
Assess and Treat from all Angles 
Assess health using 7 biophysical nodes 
Assess History to Understand Patient Complexity 
Assess Hydration 
Assess Impact of Geography to Care 
Assess Impact of Lifestyle 
Assess Mobility 
Assess Need for Imaging 
Assess Neuropathy 
Assess Patient's Spirituality with Non-Threatening Questions 
Assess the Individual Pathophysiology and Disease Progression to Assess Risk 
Assess Original Diagnosis to Confirm Risk 
Avoid a cookie cutter approach 
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Avoid compartmentalizing patient problems 
Avoid giving pain meds 
Avoid information overload, revisit some patient education later 
Avoid Making Patient Assumptions Based on Risk Level 
Avoid prescribing meds that increase other risk levels like obesity 
Avoid Setting Incorrect Expectations with Risk Assessment 
Avoid undermining another provider who may be incorrect 
Avoid use of narcotics with pregnant patients 
Avoid white coat attitude to establish comfort 
Be passionate about improving patient outcomes 
Be realistic about drug abuse and family issues 
Beware System Bias That Minimizes Individualization of Care 
Bring in other professionals based on comfort level 
Build Patient Confidence Through Gradual Wins 
Change Lifestyle to Reduce Pain 
Collaborate with Patient and Other Providers 
Collaborate with patient to create treatment plan 
Combine Herbal Meds & Therapy for Mental Health Outcomes 
Combine modalities that are not standard of care 
Communicate Tough Choices with other Providers 
Communicate with Providers 
Compare objective and subjective goals 
Compare patient history with physical exam 
Conduct 30-minute initial assessments 
Conduct a follow-up call to track outcomes 
Conduct Orthopedic Tests 
Conduct Physical Exam 
Confirm patient’s controlled substance use 
Confirm prescription use and behavior 
Confirm prescriptions in state MAP system 
Consider all patients as individuals 
Consider behaviors before surgery 
Consider conservative measures first 
Consider Contributing Factors That May Supersede Risk Level 
Consider many modalities for unique patients 
Consider Multiple Modalities 
Consider multiple sources of pain 
Consider opioid abuse and addiction 
Consider Other Providers' Perspectives 
Consider Patient Feedback 
Consider Patient Psychology if Sharing Predictions 
Consider Perspective of Treating Physician & Patient 
Consider sleep and nutrition after initial assessment 
Consider Surgery as cause of additional pain 
Consider the patient as a partner 
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Consider the patient's subjective pain scale scores 
Continue education based on patient types you typically manage 
Cooperation with Labs, Providers Reduces Insurance Issues 
Coordinate patient's search for specialists with limited availability 
Correct diagnosis allowed provider to remove unneeded meds 
Create Community of Care 
Create relaxing environment for the patient 
Create Team of Providers to Beat Cancer 
Detach to Provide Professionalism 
Discuss approach with the patient 
Discuss Biomechanical Problems Causing Pain 
Discuss Goals for Increasing QOL 
Discuss results of assessment & physical exam with patient 
Discuss role of therapy with patients 
Do not blindly accept CAM, be evidence-based 
Do not shoot down recommendations, consider them 
Do not use meds just to mask symptoms 
Don't give up-continue to suggest necessary treatment 
Earn the patients' trust 
Educate patient about benefit of laugh therapy 
Educate patient about medical hypnosis 
Educate Patient on Cause of the Issue 
Educate patient on impact of gut rest 
Educate patient on the new diagnosis 
Educate Patients on How Care Will Be Provided 
Educate Patients on Other Providers' Recommendations 
Educate Patients to Make Better Decisions 
Elicit detailed patient history 
Embrace awkward conversations with providers who disagree with treatment 
plan 
Embrace holistic approach as a Nurse 
Encourage Patients to Take on Right-Sized Spiritual Exercises 
Establish patient's ability to manage pain management contract 
Exercise patience with over-anxious patients 
Explain MDM Approach with Patient 
Explain Risks of Stopping Recommended Treatment 
Expose your humanity & fragility to connect 
Find financially realistic plan 
Focus on acute crisis stabilization 
Focus on health promotion and disease prevention 
Follow a Framework 
Follow state of MI guidelines 
Help patient assign lifestyle changes to good outcomes 
Honestly explain subset of issues that you can solve 
Identify additional stressors causing patient anxiety 
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Identify and manage substance abuse issues 
Identify Comorbidities to Assess Risk 
Identify conditions that may not be resolved during pregnancy 
Identify Contraindications 
Identify cultural, belief, and age factors impacting pain 
Identify Daily Habits that Impact Pain 
Identify economic barriers to care access 
Identify environmental factors contributing to illness 
Identify if drug abuse or misuse occurred 
Identify lifestyle changes for patients seeking to get pregnant 
Identify lifestyle modifications, meds, and therapy plan 
Identify lifestyle, daily habits, occupation, environment 
Identify Low Hanging Fruit Lifestyle Changes 
Identify medical complexities and refer patient to specialists 
Identify mental health factors impacting overall health 
Identify mental impact of chronic pain 
Identify Past Pain, Surgery, Injuries 
Identify patient diet, hydration, anxiety 
Identify patient needs and build care community 
Identify Risk in Special Populations 
Identify Risk Level 
Identify risk level of patient presenting with mental health issues 
Identify risk of substance abuse for pain patients 
Identify Short- and Long-Term Goals 
Identify the severity of mental illness 
Identify treatment options other than just giving drugs 
Identify trends to understand which additional labs to order 
Identify what cure means for the patient 
Identify when guidelines are not working and update plan 
Include family in education & decision process 
Incorporate additional modalities even if working in allopathic practice 
Identify and Heal the Underlying Cause 
Identify financial and insurance barriers to care access 
Individualize Care 
Introduce gradual changes led to improve mobility 
Introduce Spiritual options Gradually and Respectful of Differences 
Invest 1 hour in intake meeting 
Invest Time to Build Provider-Patient Trust 
Invest time to understand day in the life of the patient 
Keep Patient on Drug for QOL While Considering Other Options 
Keep the patient calm 
Lean on Expertise and Consider Alternative Options to Identify 
Recommendations 
Learn from pain experts 
Listen to the patient 
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Listen to the patient story 
Listen to your inner voice 
Log in, get recommendations from National Surgical Quality Improvement 
Program 
Maintain dynamic treatment plan 
Maintain eye contact with patients 
Maintain fine balance when prescribing pain meds 
Maintain list of providers for referral 
Make decision to reduce controlled substances 
Manage acute mental health issues aggressively 
Manage Care Plan with Team of Providers 
Manage depression presenting with pain 
Manage Diet 
Manage Lifestyle 
Manage Mental Health to Improve Compliance with Other Treatments 
Modulate Frequency of Care 
Offer Second Opinion 
Optimize patient's sleep so they can heal 
Order additional labs and ask more questions for root cause analysis 
Overcome Patient Negativity 
Paint a Vision to Inspire Patient Lifestyle Change 
Perform 1-3 Hour Initial Consultation 
Perform Acupuncture 
Perform active listening to form alliance with patients 
Perform Active Release Therapy 
Perform Functional Assessments of Risk, Outcomes 
Perform Holistic Assessment 
Perform Intake, Health History 
Perform Lab Tests 
Perform Neurokinetic Therapy 
Perform ortho Tests to recreate pain issue 
Perform root cause analysis first and then treat patient 
Perform root cause analysis to understand the deeper cause of pain 
Perform Root Cause Analysis 
Perform Ultrasound and Guided Needle Treatments 
Positively Impact QOL at a Minimum 
Practice individualized care 
Prescribe Alternatives Not Just Herbal Equivalent of a Pharmaceutical 
Prescribe herbal remedy instead of SSRI med 
Prescribe Hormone Balancing Supplements 
Prescribe Supplements 
Prescribe Supplements, Botanicals, Topical Meds 
Prioritize Patient Issues and Identify Interdependencies 
Promote a Healthy Nervous System 
Promote journaling so patients can weigh in on the care plan 
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Provide all options & the best option 
Provide chart notes to help others understand decisions made 
Provide Education Sincerely to Change Patient's Mind 
Provide Holistic Care 
Pull Out Intake Data Patients Hide 
Reach out to patients to show you care 
Realize that some patients want pills not holistic medicine 
Recognize Sports Medicine is Individualized 
Recommend Based on Lifestyle 
Recommend Gradual Change 
Recommend Lifestyle Changes and Acupuncture 
Recommend supplements, herbal remedies, calming teas 
Reconsider the results of labs & reference ranges 
Reconsider Treatment 
Reduce Confusion of Medical Jargon 
Reduce Patient Costs by Referring to Providers Who take Insurance 
Refer chronic pain patients to pain management specialist for meds 
Refer Complex patient to Functional Doc 
Refer for Surgery to Stabilize Biomechanics 
Refer Patient for Management of Psych 
Refer Patient Out if Chiro Doesn't Work 
Refer to a pain specialist 
Refer to chiro with expectations about care 
Refer to primary care for bloodwork 
Refer to specialists who can focus on pain and medication 
Refer to surgeon for evaluation and education 
Reject Previous Diagnosis After Explaining Why to Patient 
Reject Standard of Care 
Remain a stickler to standards of care 
Remain Flexible to Patients' Chiro Adoption Rate 
Remain Flexible to Patients' Resources 
Remain fluid to consider other options 
Remain open to being incorrect 
Remove Restrictive Diet Providing No Improvement 
Request more frequent visits for complex patients 
Request past disability paperwork to understand history 
Require patients to fill out a questionnaire 
Reset patient goals with expectation pain may still occur 
Respect Fact That Chiro May Not Work 
Respect opinion of other specialists 
Respect Other Providers' Opinions 
Respect patient use of chiro even if not a fan of it 
Respect patient's experience & opinion on med that works for them 
Review MRI results and update plan 
Review practice parameters to stay up to date 
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Run Food Allergy Panel to Assess Root Cause 
Run Labs and Hormone Panels as Predictive Tools 
Run Multiple Tests to Identify Causes & Root Cause of Pain 
Schedule 30-min clinical appointments for new patients 
Seek to trust the patient 
Series of Tests & Follow-up Reduced Gastro Symptoms 
Set Realistic Expectations for Lifestyle Change 
Set Realistic Expectations with Patients 
Show real concern for patients 
Show Sympathy Even When Disagreeing with Patient Choice 
Show understanding to overcome patient resistance 
Spend 30min to 1hour to assess patients 
Stabilize tough patient and then continue root cause analysis 
Stay up to date on changing guidelines 
Step back and consider back-up plans 
Supplement intake with bloodwork to predict outcomes 
Take history in initial visit 
Take Humble Approach to Empower Patient to Make Gradual Progress 
Take Less Invasive Approach 
Take Multi-Organ Approach & Address Contributing Factors 
Take time to listen to the patient 
Talk to colleagues for recommendations 
Teach breathing techniques to reduce anxiety 
Teach Holistic Approach Patiently to Analytical Patients 
Teach Patient Several Meditative Practices 
Track patient outcomes after they are referred to pain specialist 
Track subjective pain score over time 
Treat the entire person 
Triage serious issues to ER 
Try to limit use of opioids 
Understand dynamic list of controlled substances 
Understand Impact of Pain of Ability to Function 
Understand limitation of appointment time 
Understand Mechanistic Perspective 
Understand other providers may be needed 
Understand patients may not have access to healing foods 
Understand that patients may not be used to having a voice in their care 
Understand that your diagnosis may be wrong 
Understand the Patient's Individual Milieu 
Understand the Patient's Individual Situation 
Understand unique patients will score pain differently 
Understand which conventional, IM, CAM modalities a patient has used 
Use basic principles to identify risk 
Use biomechanical fixes before suggesting advanced imaging 
Use biometrics, vital signs & lab work to predict patient risk 
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Use Center of Gravity Technique for Root Cause Analysis 
Use Conferences and Consultation to get Recommendations 
Use conferences to learn new modalities and medications 
Use detailed history to understand how pain impacts lifestyle 
Use Epidemiology to Assess Risk 
Use evidence-based guidelines to direct prescribing 
Use evidence-based medicine to identify if patient is beyond lifestyle changes 
only 
Use frequent visits to predict patient outcomes 
Use genetic testing to confirm or reject complex condition 
Use gene site testing to recommend medications 
Use gut instinct and investigation to identify drug abuse 
Use handholding to establish trust 
Use hands as the only tools 
Use history and physical exam to identify risk 
Use IM websites to further education 
Use iterative conversations to educate & align on health goals 
Use journaling to identify pain triggers and predict outcomes 
Use labs to measure or predict outcomes 
Use lifestyle impact to identify risk level 
Use Light Touch Therapy to Reduce Pain 
Use Literature to get Recommendations 
Use long intake session to drive decisions 
Use MAP system to assess controlled substance risk 
Use meditation and lifestyle changes to achieve holistic results 
Use NP Therapeutic Order 
Use pain management conferences to increase knowledge 
Use patient history to perform root cause analysis 
Use patient interview to learn the back story 
Use patient medical history to determine risk 
Use Patient QOL Goal as Anchor for Root Cause Analysis 
Use Physical Exam as a Predictive Tool 
Use practice parameters to make recommendations based on diagnosis 
Use protocols based on diagnosis to recommend treatment & meds 
Use PubMed and journals to identify recommendations 
Use root cause analysis to individualize care 
Use risk stratification model for provider specialty 
Use screening questionnaires to predict outcomes 
Use several visits to establish patient trust 
Use social media to identify new terms or trends to research 
Use social workers to find resources for patients in need 
Use Spirituality as Driver for Physical Movement 
Use subjective findings 
Use subjective pain scale as tool to predict outcome 
Use support garments instead of meds for pregnant patients 
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Use the interview to understand the patient story 
Use ultrasound to predict risk in pregnant patients 
Value Patient's Goals 
View patient info on a timeline to take IM and functional approach 
Walk into patient room without bias based on their level of insurance 
Work with Supporting MD to Prescribe 
 
Table J3: Integrative and Allopathic Medicine Comparisons  
IM AND ALLOPATHIC MEDICINE COMPARISONS 
Allopathic doctors accepted & tested for incorrect diagnosis 
Allopathic focuses on symptoms not root cause analysis 
Allopathic has important role, handles urgent needs 
Allopathic medicine doesn't empower patients 
Allopathic medicine doesn't support gradual recommendations 
Allopathic medicine instructions can confuse patients 
Allopathic medicine is an assembly line 
Allopathic medicine is formulaic 
Allopathic medicine is valuable 
Allopathic medicine uses technology early versus physical exams 
Allopathic model doesn't consider the positive health factors 
Allopathic provider aggressively pushed a health protocol 
Chiropractic approach is conservative, less litigious 
Conventional medicine visits are too short to push IM 
IM Dietary changes have better effects than allopathic meds 
Doctors have different definitions of IM 
Experience grows IM provider intuition 
History of chiropractic vs American Medical Association (AMA) 
Holistic approach requires understanding of options 
Holistic care requires helping the patient heal 
Holistic medicine requires asking additional questions 
Homeopathic remedies may require patient education 
Hospitals have more control to take pain scores frequently 
Ignorance of naturopathy reduces willingness to refer 
IM addresses cancer side effects 
IM considers every modality 
IM considers preventative medicine before surgery 
IM delivers results because providers invest more time in understanding 
IM intuition includes ability to read non-verbal communication 
IM is patient-focused 
IM is the future 
IM promotes health 
IM providers all need bias training 
IM root cause analysis is different from allopathic 
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IM requires lifestyle change to promote overall wellness 
IM requires more time like a 45-min consultation 
IM requires open mind from patient, family, & care community 
IM requires patient-provider team 
IM requires patient-provider communication 
IM requires the use of specialists with time to focus on pain 
IM requires therapeutic alliance between provider and patient 
IM uses the operating room as the last resort 
It's easier to take IM approach with patients who are not pregnant 
Longer assessment allows patients to avoid potential harm 
MDs may request unneeded tests 
Mental health requires talk therapy and subjective measures 
Mental health training increases active listening skillset 
Naturopaths use a health model not a disease model 
Providers lean on their training, expertise, and intuition first 
Providers who prescribe pain meds need retraining 
Shifting to holistic medicine benefits patients & providers 
Short visits may not be able to truly cover pain 
The current US Healthcare system is broken 
Time is critical factor in medical practice 
Tracking lifestyle may become an afterthought in primary care 
US skepticism about chiropractic exists 
Unconscious bias exists in Healthcare 
 
 





Table J4: Perceptions of  PPA by Screenshot 
PPA PERCEPTION BY SCREENSHOT 
Screenshot 1 - Predictive Analytics 
1 Amount of content looks busy 
1 Avoiding race bias is good 
1 Black box predictions don't support individualized care 
1 Blanket Statements could be Inaccurate 
1 Captures Useful information about patient's living situation 
1 Change color scheme, add blues and greens, less red 
1 Clinical Risk Factors are Positive 
1 Clunky Interface 
1 Color scheme doesn't make it easy to identify areas of focus 
1 Color scheme is hard to differentiate 
1 Colors are too similar 
1 Concerns about the reliability of the information 
1 Could Bias Decision Making 
1 Different Columns in one view is good 
1 Doesn't Provide enough mental health considerations 
1 Doesn't visualize psycho-social barriers to health 
1 Dynamic of Health Not represented in Time Spans 
1 Easy to Navigate 
1 Easy to quickly see information 
1 Easy to understand patient trend (orange to red) 
1 Filters at top are easy to use 
1 Helps providers choose more aggressive steps to keep patient out of the hospital 
1 Highlighting high-risk patients is useful 
1 Improve the Color Contrast 
1 Insurance information helps understand if patient can get medications 
1 Issue with Visualization of Dots 
1 It's unclear how insurance impacts risk 
1 Iterative Status Change Supports Process 
1 Lack of comorbidities makes her question PPA 
1 Lack of visibility into readmission cause (chief complaint or something new) 
1 Lack of visibility into the care community for the patient 
1 Lacks context 
1 Looks busy 
1 More Information is Needed to Reduce Medical Error 
1 More information Needed on How Algorithm Determined Risk 
1 Neutral idea that a lot of info will create screen clutter 
1 Neutral musing about how the input was calculated 
1 Neutral response about why these headers were chosen 
1 Neutral response about accessible patient information 
1 Organization of information is good 
1 Payer Data isn't Needed for Providers who Don't take Insurance 
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1 Pigeonholes patients 
1 PPA will mirror the clutter in EMR due to amount of information to surface 
1 Presentation is Clear 
1 Presentation is straightforward 
1 PTSD and Anxiety caused by visualization 
1 Race not being captured is good 
1 Red and orange dots are hard to differentiate 
1 Red for High risk is good 
1 Reminders Help Providers Avoid Failure 
1 Reminders helps provider cover themselves 
1 Reminders of things to consider is useful 
1 Risk categories are helpful 
1 Risk factors are positive 
1 Screenshot is clunky 
1 Seems Applicable to Hospitals 
1 Sharing Predictions with Patients Leads to Negative Outlooks 
1 Should have fewer rows 
1 Simple for User with Basic Skillset 
1 Socioeconomic factors may trigger certain providers 
1 Sorting features are good 
1 Surfaces a lot of valuable information 
1 Surfacing insurance payer could introduce bias 
1 User experience is neutral aesthetically 
1 Visualization of dots isn't appealing 
Screenshot 2 - Prescriptive Analytics 
2 Accuracy of Historical Data Impacts PPA Outputs 
2 Additional information supports care planning for release from hospital 
2 Background information helps Provider Show Bedside Manner 
2 Brief patient snapshot is helpful 
2 Clinical risk factors and laboratory information is helpful 
2 Clinical risk factors may be helpful 
2 Color scheme is not good-needs more color 
2 Comprehensive view is not bad 
2 Concern that uninsured patients would get different outputs 
2 Consideration of Options Based of Individual Factors Has Value 
2 Cookie Cutter Protocols don't support IM 
2 Date added to the system not helpful 
2 Does the patient research for the provider 
2 Doesn't calculate age automatically 
2 Doesn't highlight what is current versus resolved 
2 Doesn't Support Preventative Medicine 
2 Has Value for Extreme Cases (e.g., Death Risk) 
2 Has value for new mental care professionals 
2 Helps IM provider create better care plan 
2 If payer name means nothing, remove it 
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2 Improve user interface & add colors 
2 Income Doesn't Factor in Choices a Patient Makes 
2 Insurance Payer is Irrelevant to Care Decisions 
2 Interventions list may help save time 
2 Is too generic 
2 Is very comprehensive 
2 Lack of color scheme makes it hard to know where to focus 
2 Lacks Drill down into diagnosis and clinical factors 
2 Less helpful for mental health professions who assess patients effectively 
2 Less Negative than screenshot 1 
2 List of Interventions Provides Reminders 
2 List of issues should be grouped by ICD code 
2 Living alone status is more important than marriage status 
2 More diagnosis history is needed 
2 More visually appealing than screenshot 1 
2 Neutral reaction to new information moving closer to holistic approach 
2 Patients Appreciate Not Having to Repeat History with Every Provider Visit 
2 Payer name should not introduce bias 
2 Provides prompts on which additional providers & support to coordinate 
2 PPA Discrepancy May Require Audit of Data Inputs 
2 PPA Doesn't take into Account Patient Presentation 
2 Presentation is busy, but serves a purpose 
2 Protocols Support Critical Conditions better than Chronic Conditions 
2 Provides Aggregate Data to Support Intake 
2 Provides more behind-the-scenes information 
2 Provides more input on WHY a patient has a certain risk score 
2 Provides patient snapshot that informs first steps 
2 Provides understanding of patient lifestyle 
2 Provides value like care gaps identified by some EMR systems 
2 Providing risk factors is valuable 
2 Recommendations are too Generic 
2 Reminders are Especially Helpful if the Outcome of Missing is Dire 
2 Replaces Need to Review Large Volume of Documents 
2 Requires orientation or help to digest large amount of data 
2 Requires time to understand what content is presented 
2 Risk Factors Are Presented Simply 
2 Socioeconomic Data Supports Selection of Appropriate Interventions 
2 Socioeconomic factors like education may create bias 
2 Some socioeconomic risk factors are very helpful 
2 Summarizes large amount of data 
2 Surfaces IM Options to Educate Allopathic Providers 
2 Too Much Content on Screen 
2 Topics presented are extremely helpful 
2 Unclear if this is point in time data or representing a trend 
2 Understanding socioeconomic factors helps identify barriers to access 
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2 Visualization of socioeconomic risks has value 
Color Code 2 To Make Key Content Stand Out 
Screenshot 2 Presents Better Than Screenshot 1 
Screenshot 3 Interventions, Recommendations 
3 Age without having to calculate is helpful 
3 All purple makes it difficult to differentiate sections 
3 Allowing provider to accept or reject a recommendation is valuable 
3 Allows ML to Occur, Better over Time 
3 Allows others to see your action on the recommendations 
3 Benzo Encounters risk lacks information 
3 Best screenshot - shows care gaps similar to EMR 
3 Big Picture Summary is Similar to Notation IM Provider Currently Captures 
3 Capturing status allows provider to update over time 
3 Comprehensive view of information is good 
3 Data presented best out of the three screenshots 
3 Drop down increases accountability 
3 Functionality Lacks Ability to Add Context 
3 Keeps the provider on their toes, to not miss information 
3 Knowing status of other's actions is helpful 
3 Lack of clarity on the nature of the issue 
3 Lack of Visibility into How PPA Makes Recommendation causes Doubt 
3 Lack of visibility into how long the issue has existed 
3 Lack of visibility into whether risk factors are primary or secondary 
3 List Provides Reminders for Providers to Ask About Previous History 
3 Lists Provider Reminder of What to Ask the Patient 
3 Length of stay (LOS) is helpful for hospitalists 
3 Makes it easier to distinguish areas of content 
3 Medical Decision-Making is More Dynamic Than Drop-Down Menu 
3 More information is needed about the risk factors 
3 More information on drug encounters is needed 
3 Presents information in a more focused way 
3 Presenting Comorbidities helps providers reconsider treatment plan 
3 Prompts are useful for busy professionals 
3 Provider Did not Like Patients Being Ranked 
3 Providers Less Likely to Choose Unfamiliar Recommendations  
3 Providing Clear Snapshot Creates Individualized View 
3 Purple color scheme is not differentiated enough 
3 Recommendations Lack Individualization 
3 Recommendations Shouldn't be Applied Generically 
3 Requires a learning curve to understand information presented 
3 Screen looks busy 
3 Selected Status Could Be Used to Judge Physicians 
3 Selecting Status Makes Assumption Provider is following Pre-Set Protocol 
3 Sort feature is user friendly 
3 Status drop down is fair 
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3 Supports Groups of Data Captured in IM Assessments 
3 Surfacing Patient support system is valuable 
3 Surfacing Patient's Ethnicity would introduce bias 
3 Tracking Acceptance of Recommendations Has Value 
3 Tracking actions helps practice managers audit treatment protocols 
3 Unclear if Recommendation is Standard of Care 
3 Visualizing status helps provider know what's outstanding 
3 Works for Hospitals, Makes Finding Information Efficient 
Table J5: Healthcare Scenarios Best Supported by PPA 
SCENARIOS BEST SUPPORTED BY PPA 
Best for complex patients 
Best for pain patients with obvious cause (like a fall) 
Best for patients who may fall through the cracks 
Best for preventative care 
Best for systems that already have well-defined risk scoring 
Best used as tool to educate provider on patient history 
Best used in patients with one well-understood issue like diabetes 
Best for management of chronic emergent disease 
PPA fits chronic disease patients with well understood actions & treatments 
Best for providers using factors to prescribe medication 
Best for providing recommendations a provider may miss 
Hospitalists using PPA share risk scores to primary care provider 
PPA supports mental health safety assessment 
PPA has more value making recommendations using mental health questionnaires 
PPA is suitable for educating all types of patients 
PPA is well suited for titrating patients off medications over time 
PPA makes performing intake, cataloguing, and retrieving data more efficient 
PPA provides information which can make the visit experience more engaging 
PPA provides workflow for what to do with the patient 
PPA supports emergency scenarios best 
PPA surfaces information providers don't always remember 
 
Table J6: Current Limitations of PPA (Negative Perception) 
CURRENT LIMITATION OF PPA 
AI and machine learning fan questions PPA Healthcare application 
Algorithms based on allopathic medicine is a sick society model 
Automatically suggesting a medication would increase doubt in PPA 
Data input error reduces PPA accuracy 
Denying a patient care based on PPA is inappropriate 
Doubt about ability to apply predictive analytics to individuals 
Doubt that PPA support aggregate data needs of IM 
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Downstream provider ease, confidence relies on upstream data entry 
Focus on lists distracts from focus on outcomes 
Human error in data entry creates doubt about PPA 
Inability to process non-verbal communication creates doubt in PPA 
Inconsistency is data entry causes provider to doubt PPA 
Incorrect data input would cause doubt of results 
Lack of visibility causes provider to doubt PPA 
Lack of visibility into algorithms causes doubt 
Low reliability would cause doubt in PPA 
Obvious errors would create doubt in PPA 
Patients may reject data transparency needed to support PPA 
Physiology of women in labor is not going to fit the algorithm 
PPA can't predict suicide 
PPA could push allopathic doctors to pigeonhole patients 
PPA creates latency issue, impact of real time info 
PPA designed without patient input increases doubt in the system 
PPA dictated care based on insurance is negative 
PPA doesn't capture patient feedback about medication 
PPA doesn't consider impact of racial bias 
PPA doesn't consider medicine/treatment compliance 
PPA doesn't consider physical presentation of patient 
PPA doesn't consider subjective factors 
PPA doesn't manage subjective conditions 
PPA doesn't support functional screening 
PPA doesn't support real time data 
PPA doesn't track data chiropractors need 
PPA grouping of people is a problem in medicine 
PPA has incorrectly predicted psychiatric hospital admittance 
PPA has limitations for patient surrogate & interpreter situations 
PPA is not a fit for CAM or holistic medicine 
PPA is not a good fit for depressed patients with complicated histories 
PPA is surfacing too much information, looks busy 
PPA lacks holistic considerations 
PPA limitation is the massive amount of data needed to be accurate 
PPA is limited to people with internet 
PPA may not be able to surface sealed mental health records 
PPA is not fit for capturing information from patients who have guardians 
PPA results that go against provider intuition would cause rejection 
PPA that doesn't consider less invasive modalities would be met with doubt 
PPA tools could make practitioners lazy 
PPA wasn't designed for body workers 
PPA wasn't designed for paper-based practitioners 
Rejection of PPA for clinical decision-making 
Removal of human interaction would increase doubt of PPA 
Socioeconomic labels have negative connotations 
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Systems often create a transcription burden 
Test or imaging results may distract from root cause of pain 
 
Table J7: Beliefs and Attitudes on Future Convergence of IM and PPA 
BELIEFS AND ATTITUDES ON FUTURE CONVERGENCE OF IM AND PPA 
Belief in PPA improvement did not reduce doubts about future accuracy 
Convergence should occur if providers aren’t relying solely on PPA 
Convergence could occur to provide toolkit of treatment options 
Convergence doesn't support reality of complex patients 
Convergence is inevitable due to general acceptance of technology 
Convergence of prescriptive analytics using generalization should not occur 
Convergence should occur with accurate data inputs 
Convergence will occur because AI is more accurate than human decision-making 
Convergence will occur because PPA is already in use 
Convergence will occur because PPA reconciles so much information 
Future PPA can educate providers on treatment options 
Future PPA should not reduce human interaction 
Future PPA gives insights via mobile devices 
Future PPA must aid not introduce additional time constraints 
Future PPA must consider barriers to care 
Future PPA requires future EMR 
Future PPA requires insurance payers to see value 
Future PPA that tracks lifestyle highlights additional things providers miss 
Future PPA will be driven by epigenetics 
Future PPA will be used to convince patients of their risk and educate them on 
benefits of lifestyle change 
Future PPA will give additional options for providers to consider 
Future PPA will incorporate IM and Allopathic 
Future PPA will require patient reported data 
Future PPA will use lab data and patient outcomes to drive machine learning 
Future state systems (EHR) should reduce manual transcription 
Future systems should surface conventional & CAM recommendations 
Hacking risk reduces comfort with total PPA dependence 
Ideal PPA requires integration between IM and allopathic systems 
Monitoring of dynamic data will improve PPA value 
PPA will help IM when patients shift to emergency issues 
PPA will surface next steps for patients with severe conditions 
PPA confidence requires big data input 
PPA could unify medical practice via visibility into holistic patient 
PPA is inevitable but hurts art of medicine 
PPA is not going away 
PPA needs rethinking for convergence to occur 
PPA needs to be tweaked for convergence 
PPA replacement of mental health evaluation is unlikely 
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PPA replacing decision-making is unlikely 
PPA should inform IM decisions but not dictate them 
PPA should not determine admittance to mental health facility 
PPA use will increase 200% 
PPA will be a good start to helping patients but requires provider root cause 
analysis 
PPA will be adopted in 10 years 
PPA will be an adjunct not a replacement of human decision 
PPA will be education tool for providers who weren't trained to think holistically 
PPA will be more readily used in 10 years 
PPA will be used in primary care & IM in 10 years 
PPA will clarify decision-making and identify details providers forget 
PPA will create ROI, thus will be adopted 
PPA will depend on future interoperability 
PPA will have same human data entry errors as paper 
PPA will integrate with IM-specific EHR 
PPA will not remove human element (chaos) 
PPA will not replace decision-making 
PPA will not replace human discernment 
PPA will not replace sports medicine decision-making 
PPA will reduce mistakes caused by missing information 
PPA will remind doctors which medications to use 
PPA will replace the surgical clearance visit 
PPA will require connected patients with at-home devices 
PPA will support decision-making but not replace it 
PPA will take over in 10 years 
PPA will use lab data to identify contraindications to medications 
PPA will use labs to identify sexually transmitted infection (STI) treatment 
PPA won't replace value of physical presentation 
Provider expertise trumps system recommendations 
Provider trusted PPA due to generational trust of technology 
Separation of medical disciplines makes holistic PPA difficult to achieve 
The future of non-emergency scenarios is individualized care 
      
Table J8: Proposed PPA Modifications, Additional Inputs & Outputs 
PROPOSED PPA MODIFICATIONS, ADDITIONAL INPUTS & OUTPUTS 
Add bi-directional communication, messaging 
Add task management workflow 
Adding correlation of lifestyle change to outcome would impact patient behavior 
Allow addition of notes 
Allow provider to deselect or reduce value of risk factors 
Automate data capture of visit summaries 
Capture concomitant medications and show interactions 
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Capture patient compliance to understand their mentality towards change 
Choose colors that make status easier to see 
Drill down into risk factor bullet point for more context 
Future PPA should use patient input-market research 
Imaging capability is needed for PPA to compete with EHR 
Include subjective measures 
Inclusion of imaging could expose trends 
Integrate with specialty labs 
Interoperability, federated data is needed 
PPA algorithms should mirror evidence-based practice 
PPA must collect data to present metrics while saving time 
PPA recommendations must be designed based on IM protocols 
PPA should calculate hydration goals based on patient weight 
PPA should identify areas of follow up based on genetic testing 
PPA should allow drills downs into red flag opioid risk scores 
PPA should allow dynamic data entry, add or remove history elements 
PPA should allow note boxes for free text entry of additional data 
PPA should allow patients to review contract via mobile/web 
PPA should allow providers & patients to select status of behavior change 
PPA should allow providers to refine modality menu, educate patient on options 
PPA should allow selection of multiple providers in patient chart 
PPA should amplify social workers’ role 
PPA should surface clinical determination and allow providers to override it 
PPA should automate referral message like the eClinical Works system 
PPA should blind factors that could cause bias 
PPA should calculate morphine dose equivalent 
PPA should calculate time to next outpatient mental health visit 
PPA should capture baseline & ongoing snapshot of antipsychotics' impact 
PPA should capture lifestyle in patient health questionnaire (PHQ) 
PPA should capture mental health safety assessment answers 
PPA should capture objective mental health factors like hospitalization frequency 
PPA should capture pain scores over time 
PPA should capture past & current meds, current physical symptoms 
PPA should capture patient feedback 
PPA should capture patient-reported happy face scores for pain 
PPA should capture previous injuries 
PPA should capture QOL improvements (outside of the pathology) 
PPA should capture real-time pain scores 
PPA should capture some tests more frequently 
PPA should collect visit summaries with short- & long-term treatment strategy 
PPA should complement not replace the physician 
PPA should connect physical exams to impact of predictions 
PPA should connect to the pharmacy and track compliance with medications 
PPA should connect with state automated prescribing system 
PPA should consider patient feedback in lifestyle suggestions 
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PPA should correlate lifestyle to patient reported outcomes, subjective scores 
PPA should educate the patient on modality options based on the diagnosis 
PPA should flag issues based on patient history 
PPA should have alerts if pain contract is being broken 
PPA should highlight abnormal lab results 
PPA should highlight the patient’s priorities 
PPA should identify barriers to care for specialists 
PPA should identify resources based on need and insurance coverage 
PPA should include additional section for habits 
PPA should include and measure QOL, blisters or positive markers 
PPA should include drop down of all diagnoses 
PPA should include the why-physician goals & reason for prescribing medications 
PPA should integrate with EMR to track referrals 
PPA should integrate with note-taking system to capture interviews 
PPA should link to medical images listed as a risk factor 
PPA should list barriers to care 
PPA should make lifestyle tracking front and center 
PPA should mirror EMR pharmacy integration & medicine reconciliation 
PPA should mirror the iterative way practice parameters are updated 
PPA should not take discernment away from providers 
PPA should notify social workers added to care community 
PPA should predict risk of sending mental health patients back to the home setting 
PPA should prioritize interventions by level of importance 
PPA should prompt providers to perform necessary follow-up calls or visits 
PPA should provide alerts around state-mandated morphine dose equivalence 
PPA should provide enough info on risk factors to prompt order of additional tests 
PPA should provide hover help that links to articles & guidelines 
PPA should provide listings by decision status 
PPA should recommend lifestyle changes based on risk 
PPA should recommend labs to take based on mental health risk 
PPA should recommend placement options for mental health patients 
PPA should record functional recovery times 
PPA should recommend disposition planning next steps 
PPA should reduce need for manual transcription 
PPA should reference images found in medical manuals 
PPA should share links to patient education info 
PPA should show most frequently referred based on specialty and distance 
PPA should suggest diet options based on patient history 
PPA should support comments on patient charts 
PPA should support curation of frequently changing modalities 
PPA should support EMR box click functionality to dictate patient history 
PPA should support interoperability, capturing data from multiple providers 
PPA should support matrix of patient data over time 
PPA should support nurse review of screening answers 
PPA should support patient reported lifestyle and diet behaviors 
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PPA should support patient selection of referral providers 
PPA should support portability of patient records from system to system 
PPA should support real-time data entry & provide feedback to patients 
PPA should support real-world documentation workflow, prompts for next steps 
PPA should support several different risk models 
PPA should support SOAP notes with the assessment and treatment plan 
PPA should surface content in disability paperwork 
PPA should surface information to social workers to drive care planning 
PPA should surface intake information as historical data 
PPA should surface key information to newly added care provider 
PPA should surface list of CAM providers regardless of insurance 
PPA should surface list of medical images by date taken 
PPA should surface opioid risk scores from state systems 
PPA should surface patient & treating physician's perspective 
PPA should surface patient screening on an app 
PPA should surface recommendations as a provider workflow 
PPA should surface up-to-date resources, websites, and information on NM 
PPA should track elements of the pain contract 
PPA should track initial lifestyle and changes over time 
PPA should track patient satisfaction with provider, staff, & facility over time 
PPA should track provider list with contact information 
PPA should track providers' visits 
PPA should track subjective pain measures with anecdotal data over time 
PPA should use objective data like vitals to drive risk areas 
PPA should validate algorithms based on patient type (edge cases) 
PPA should surface list of past providers 
Provide customizable & dynamic workflow to support patient assessment 
Recommend alternative medications 
Share medical history, past interventions 
Sharing protected information will be difficult 
Suggest less invasive therapy 
Suggest more invasive therapy 
Support mental health assessment 
Surface recommendations by provider type 
Surface recommendations from ecosystem of providers 
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